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Clinical PerspectiveWhat Is New?Our study, using a porcine developmental model, demonstrates the dynamic relationship between fractional anisotropy, the clinically relevant biomarker for studying white matter development and pathology, and cellular events after pediatric cardiac surgery.Our analysis identifies region‐specific white matter vulnerability to insults associated with cardiac surgery and reveals that white matter regions in the frontal cortex are particularly susceptible after cardiopulmonary bypass.In conjunction with detailed cellular assays, the present study suggests that alterations of fractional anisotropy are affected by oligodendrocyte dysmaturation, astrogliosis, and microglial expansion due to cardiopulmonary bypass.What Are the Clinical Implications?Fractional anisotropy in the frontal cortex should be a clinically relevant biomarker in white matter injury after cardiac surgery.Reducing and recovering alterations of oligodendrocyte development in the frontal cortex can be both a metric and a goal to improve life‐long neurodevelopmental consequences in children with congenital heart disease.

Introduction {#jah32429-sec-0008}
============

Hospital mortality for neonates and infants with severe/complex congenital heart disease (CHD) has dramatically improved over the past 2 decades.[1](#jah32429-bib-0001){ref-type="ref"} However, many survivors of complex CHD repair are at significant risk for important neurodevelopmental morbidity.[1](#jah32429-bib-0001){ref-type="ref"}, [2](#jah32429-bib-0002){ref-type="ref"}, [3](#jah32429-bib-0003){ref-type="ref"}, [4](#jah32429-bib-0004){ref-type="ref"} Within a wide range of brain regions, newly developed postoperative white matter (WM) injury is common.[5](#jah32429-bib-0005){ref-type="ref"}, [6](#jah32429-bib-0006){ref-type="ref"}, [7](#jah32429-bib-0007){ref-type="ref"} It has been well established that alterations of the WM microstructure persist into later life,[8](#jah32429-bib-0008){ref-type="ref"} and impairments of neural connectivity due to WM injury cause neurological dysfunction including attention deficit, executive dysfunction, impairment of working memory, and verbal dysfunction.[8](#jah32429-bib-0008){ref-type="ref"}, [9](#jah32429-bib-0009){ref-type="ref"}, [10](#jah32429-bib-0010){ref-type="ref"} Because these deficits are remarkably similar to neurodevelopmental morbidity in patients with severe/complex CHD,[3](#jah32429-bib-0003){ref-type="ref"}, [11](#jah32429-bib-0011){ref-type="ref"}, [12](#jah32429-bib-0012){ref-type="ref"} it is likely that the extent of abnormal WM development early in life accounts for the type and degree of neurological deficits observed in the CHD population.[13](#jah32429-bib-0013){ref-type="ref"}

Limited sensitivity and specificity in conventional magnetic resonance imaging (MRI) have prevented direct linking of quantitative/semiquantitative image results with neurological outcomes in CHD.[13](#jah32429-bib-0013){ref-type="ref"} Diffusion tensor imaging (DTI) is a powerful MRI technique that can measure macroscopic organization for studying WM pathology.[14](#jah32429-bib-0014){ref-type="ref"} Fractional anisotropy (FA) obtained from DTI has been widely used to detect a variety of WM injuries and to quantify the pathological state.[15](#jah32429-bib-0015){ref-type="ref"} Indeed, despite scant WM injury evident on conventional MRI, adolescents with d‐transposition of the great arteries repaired in infancy had WM regions with significantly lower FA.[16](#jah32429-bib-0016){ref-type="ref"} In those adolescents WM FA reductions were associated with their neurocognitive deficits.[17](#jah32429-bib-0017){ref-type="ref"} The development of innovative image‐processing technology is now enabling us to introduce such advanced neuroimaging in the fetus and neonate.[18](#jah32429-bib-0018){ref-type="ref"} Therefore, future clinical imaging studies paired with neurological outcome investigations will greatly assist our understanding of WM damage at a microstructural level and will facilitate correlation with specific developmental and behavioral disabilities in patients with CHD.

There is a clear need for animal studies incorporating clinically relevant imaging approaches paired with histological analysis to CHD‐induced brain insults. In conjunction with clinical research, studies of this nature will aid in acquiring a full picture of CHD‐induced abnormal WM development and injury and will likely lead to development of novel treatment and management strategies for reduction of neurodevelopmental morbidity in children with severe/complex CHD.

Previous attempts to study WM injury using rodent models have been limited by structural differences with the human brain. In the human brain WM occupies ≈50% of the total brain volume, whereas in rodents it is only 15%.[19](#jah32429-bib-0019){ref-type="ref"} In contrast the piglet brain is a powerful model to study human brain development as it displays a highly evolved, gyrencephalic neocortex structurally similar to the human brain.[20](#jah32429-bib-0020){ref-type="ref"} Furthermore ≈50% of the piglet brain volume is represented by WM.[21](#jah32429-bib-0021){ref-type="ref"} Finally the piglet is large enough in the newborn period for investigation using cardiopulmonary bypass (CPB),[22](#jah32429-bib-0022){ref-type="ref"}, [23](#jah32429-bib-0023){ref-type="ref"} which can result in unique and specific pathological conditions in the developing brain with CHD.[13](#jah32429-bib-0013){ref-type="ref"} In order to enable improved interpretation of human DTI studies at the cellular level, the aims of the present study were (1) to characterize development of the gyrencephalic WM in a unique developing porcine model; (2) to define alterations of WM microstructures after cardiac surgery with DTI; and (3) to determine correlation of FA changes with CPB‐induced cellular events using our histological approach.

Methods {#jah32429-sec-0009}
=======

Experimental Model {#jah32429-sec-0010}
------------------

CPB results in systemic inflammatory response syndrome (SIRS) due to blood exposure to nonendothelial surfaces, such as the artificial oxygenator, tubing, and cannulas.[24](#jah32429-bib-0024){ref-type="ref"} In addition, CHD patients are at greater risk of global cerebral ischemia during CPB, resulting from blood steal syndrome due to aortopulmonary collateral vessels and possible cerebral vessel abnormality.[25](#jah32429-bib-0025){ref-type="ref"}, [26](#jah32429-bib-0026){ref-type="ref"} Embolism of both solid particles and gaseous emboli due to CPB is also an important cause of ischemia‐reperfusion/reoxygenation (I/R) injury.[26](#jah32429-bib-0026){ref-type="ref"} Finally, the circulatory arrest technique still involves risk of I/R‐injury such as the "no‐reflow phenomenon."[27](#jah32429-bib-0027){ref-type="ref"} To investigate the effects of CPB on WM development, therefore, piglets at 3 weeks of age were randomly assigned to 1 of 3 groups exposed to different CPB‐induced brain insults involving I/R injury and SIRS (Figure [1](#jah32429-fig-0001){ref-type="fig"}A): (1) control (sham surgery, no CPB‐induced insult, n=3); (2) 34°C full‐flow bypass for 60 minutes (mild CPB insult, CPB‐induced SIRS, n=4); and (3) 25°C circulatory arrest for 60 minutes (severe CPB insult, CPB‐induced SIRS with I/R injury, n=6). We performed all experiments in compliance with the NIH *Guide for the Care and Use of Laboratory Animals*. The study was approved by the Animal Care and Use Committee at Children\'s National Medical Center.

![CPB‐induced insult and porcine WM structures. A, Study design of the CPB groups. More data are presented in Table [1](#jah32429-tbl-0001){ref-type="table-wrap"}. B, The anatomical location and example of drawn and quantified region of interests in porcine WM structures on directionally encoded color map. ALIC indicates anterior limb of the internal capsule; BCC, body of the corpus callosum; CA, circulatory arrest; CingWM, cingulum white matter; Cool, cooling; CPB, cardiopulmonary bypass; DTI, diffusion tensor imaging; FF, full‐flow perfusion; GCC, genu of the corpus callosum; Ht, hematocrit level; I/R, ischemia‐reperfusion/reoxygenation; IFWM, inferior frontal white matter; L‐PVWM, lateral periventricular white matter; MFWM, middle frontal white matter; M‐PVWM, medial periventricular white matter; NT, normothermia; PLIC, posterior limb of the internal capsule; PrCWM, precentral white matter; PTR, posterior thalamic radiation; RLIC, retrolenticular limb of the internal capsule; RW, rewarming; SCC, splenium of the corpus callosum; Sev., severe‐CPB insult; SFWM, superior frontal white matter; SIRS, systemic inflammatory response syndrome; SLF, superior longitudinal fasciculus; SPWM, superior‐parietal white matter; WM, white matter.](JAH3-6-e005997-g001){#jah32429-fig-0001}

Preparation for Surgery {#jah32429-sec-0011}
-----------------------

All animals were sedated with intramuscular ketamine and xylazine and intubated with a 4.5‐mm cuffed endotracheal tube. Each animal was ventilated at an inspired oxygen fraction of 0.21 and a rate of 12 to 15 breaths/min, by means of a volume‐control ventilator (Servo Ventilator 300; Siemens, New York, NY) to achieve a normal pH and arterial carbon dioxide tension of 35 to 40 mm Hg. Intravenous bolus injections of fentanyl and pancuronium via a peripheral intravenous line were administered before surgery. Anesthesia was maintained by a continuous infusion of fentanyl, midazolam, and pancuronium throughout the entire experiment. Heterologous blood was obtained from a donor Yorkshire pig with weight of 35 to 45 kg that had been anesthetized with telazol and xylazine. Under anesthesia an intravenous cannula was placed in each femoral vein to obtain the blood. Heparin was administered intravenously. The donated blood was used to prime the CPB circuits for the experimental animals.

Surgery and Cardiopulmonary Bypass {#jah32429-sec-0012}
----------------------------------

All surgical procedures were performed under sterile conditions. Two cannulas (19G Intracath; Becton Dickinson, Sandy, UT) were inserted in the right femoral artery and vein, respectively, for continuous blood pressure monitoring and blood sampling and continuous infusion. For the perioperative temperature monitoring, temperature probes were placed in the esophagus and rectum. A right anterolateral thoracotomy was performed through the third intercostal space to expose the ascending aorta for arterial cannulation and the right atrium for venous cannulation, respectively. After systemic heparinization (300 IU/kg) administered intravenously, a 10F arterial cannula (Medtronic Bio‐Medics, Minneapolis, MN) and a 22F venous cannula (Research Medical Inc, Midvale, UT) were inserted into the ascending aorta and right atrial appendage, respectively. The CPB circuit consisted of a roller‐pump (Cardiovascular Instrument Corp; Wakefield, MA), membrane oxygenator (Minimax; Medtronic Inc, Anaheim, CA), and sterile tubing with 40‐μm arterial filter. Fresh whole blood from a donor pig was transfused into the CPB circuit in order to adjust the hematocrit level to 30%.[28](#jah32429-bib-0028){ref-type="ref"}, [29](#jah32429-bib-0029){ref-type="ref"}, [30](#jah32429-bib-0030){ref-type="ref"} The pump prime included normal saline, methylprednisolone (30 mg/kg), furosemide (0.25 mg/kg), sodium carbonate (10 mL), and cephazolin sodium (25 mg/kg). The pH‐stat strategy was employed by the use of sweep gas 95% O~2~/5% CO~2~.[31](#jah32429-bib-0031){ref-type="ref"}, [32](#jah32429-bib-0032){ref-type="ref"} CPB was started, and the animals were perfused for 10 minutes at an esophageal temperature of 37°C. Subsequently animals were cooled to an esophageal temperature of 25°C or 34°C according to the experimental protocol. Ventilation was stopped after the establishment of CPB. After cooling, circulatory arrest or maintenance of full flow was chosen according to the protocol. Duration of the circulatory arrest period was 60 minutes. During the rewarming period the heart was defibrillated as necessary at an esophageal temperature of 30°C. Ventilation was started 10 minutes before weaning from CPB. After 40 minutes of rewarming, animals were weaned from CPB. The hematocrit level of 30% was maintained, and pH‐stat strategy was performed as described in the current clinical CPB technique.[26](#jah32429-bib-0026){ref-type="ref"}, [29](#jah32429-bib-0029){ref-type="ref"} Mean and systolic arterial pressure and esophageal and rectal temperature were monitored continuously throughout each experiment and were recorded every 10 minutes. Arterial [po]{.smallcaps} ~2~ and [pco]{.smallcaps} ~2~, arterial pH, hematocrit value, mixed venous oxygen saturation, and arterial lactate were measured with a blood gas analyzer (Rapidlab 1200; Siemens, New York, NY) every 15 minutes on CPB, at 30 minutes after conclusion of CPB, and once an hour up to extubation on postoperative day 1.[33](#jah32429-bib-0033){ref-type="ref"} The tissue oxygen index was measured using near‐infrared spectroscopy.[33](#jah32429-bib-0033){ref-type="ref"} Neurological and behavioral evaluations were performed blindly at 24‐hour intervals beginning on postoperative day 1. Experimental conditions are described in Table [1](#jah32429-tbl-0001){ref-type="table-wrap"}.

###### 

Experimental Conditions

  CPB Groups                            Control (n=3)   Mild CPB (n=4)   Severe CPB (n=6)   F‐Test   *P* Value   Control vs Mild CPB   Control vs Severe CPB   Mild CPB vs Severe CPB                       
  ------------------------------------- --------------- ---------------- ------------------ -------- ----------- --------------------- ----------------------- ------------------------ --------- --------- ---------
  Body weight, kg                       5.0             0.8              4.6                0.9      4.8         0.8                   0.17                    0.844                                        
  Tissue oxygen index                                                                                                                                                                                       
  Pre‐CPB                               50.0            4.4              45.1               2.8      48.1        2.6                   2.24                    0.157                                        
  Pre‐FF/CA                             50.7            3.8              56.6               1.3      66.7        4.2                   23.49                   \<0.001                  0.158     \<0.001   0.004
  FF/CA                                 53.3            4.3              57.0               1.3      34.0        2.9                   87.01                   \<0.001                  0.384     \<0.001   \<0.001
  Post‐FF/CA                            50.6            5.3              52.4               2.0      52.4        1.6                   0.46                    0.643                                        
  Post‐CPB                              51.2            5.0              49.7               2.4      47.2        2.0                   2.09                    0.175                                        
  Mean blood pressure, mm Hg                                                                                                                                                                                
  Pre‐CPB                               88.2            3.3              76.6               17.7     79.6        20.7                  0.39                    0.689                                        
  Pre‐FF/CA                             88.4            3.3              96.0               6.0      101.3       4.7                   6.92                    0.013                    0.213     0.012     0.379
  FF/CA                                 87.1            5.0              99.1               7.4      4.8         1.7                   568.20                  \<0.001                  0.024     \<0.001   \<0.001
  Post‐FF/CA                            86.7            5.6              112.7              11.8     111.6       20.4                  2.91                    0.101                                        
  Post‐CPB                              83.4            4.6              92.9               15.7     82.4        7.6                   1.35                    0.302                                        
  Esophageal temperature, °C                                                                                                                                                                                
  Pre‐CPB                               36.6            1.1              36.3               1.2      36.3        1.2                   0.05                    0.951                                        
  Pre‐FF/CA                             36.7            1.2              34.6               0.3      28.9        1.1                   76.50                   \<0.001                  0.050     \<0.001   \<0.001
  FF/CA                                 36.9            1.2              33.6               0.7      25.0        1.1                   172.10                  \<0.001                  0.004     \<0.001   \<0.001
  Post‐FF/CA                            37.0            1.3              36.9               0.6      36.5        1.1                   0.32                    0.732                                        
  Post‐CPB                              36.9            1.3              37.8               0.5      37.3        0.8                   1.18                    0.347                                        
  Pa[o]{.smallcaps} ~2~, mm Hg                                                                                                                                                                              
  Pre‐CPB                               101.5           11.3             108.0              6.6      98.0        11.0                  1.20                    0.341                                        
  Pre‐FF/CA                             94.5            13.4             548.8              46.3     574.8       42.5                  161.50                  \<0.001                  \<0.001   \<0.001   0.999
  Post‐FF/CA                            93.3            11.8             549.5              28.1     503.9       35.6                  239.00                  \<0.001                  \<0.001   \<0.001   0.121
  Post‐CPB                              95.5            10.2             121.9              27.9     122.7       25.9                  1.42                    0.287                                        
  Pa[co]{.smallcaps} ~2~, mm Hg                                                                                                                                                                             
  Pre‐CPB                               33.2            12.5             31.4               1.4      31.5        9.2                   0.05                    0.955                                        
  Pre‐FF/CA                             35.4            9.5              40.7               3.1      42.7        3.5                   1.99                    0.187                                        
  Post‐FF/CA                            38.1            5.5              39.7               1.4      39.9        4.3                   0.21                    0.812                                        
  Post‐CPB                              37.1            5.1              32.1               5.1      31.3        5.6                   1.25                    0.327                                        
  PH                                                                                                                                                                                                        
  Pre‐CPB                               7.64            0.09             7.67               0.10     7.62        0.10                  0.30                    0.745                                        
  Pre‐FF/CA                             7.60            0.04             7.51               0.04     7.46        0.04                  11.40                   0.003                    0.061     0.002     0.234
  Post‐FF/CA                            7.56            0.03             7.54               0.04     7.43        0.02                  25.40                   \<0.001                  0.999     \<0.001   0.001
  Post‐CPB                              7.55            0.04             7.61               0.07     7.57        0.09                  0.61                    0.563                                        
  Hematocrit, %                                                                                                                                                                                             
  Pre‐CPB                               37.2            2.4              37.1               3.6      38.4        2.4                   0.34                    0.721                                        
  Pre‐FF/CA                             36.7            2.3              34.3               2.0      34.2        2.7                   1.13                    0.361                                        
  Post‐FF/CA                            36.3            1.6              33.5               1.4      33.9        2.5                   1.85                    0.208                                        
  Post‐CPB                              36.6            3.4              36.9               1.6      34.5        3.0                   1.11                    0.367                                        
  Leukocyte number, ×10^3^/μL                                                                                                                                                                               
  Pre‐CPB                               5.8             0.4              5.5                1.6      6.4         1.8                   0.38                    0.691                                        
  Pre‐FF/CA                             6.3             2.2              6.6                2.0      4.4         1.1                   0.38                    0.691                                        
  Post‐FF/CA                            6.9             2.6              7.2                1.8      7.6         2.7                   0.07                    0.929                                        
  Post‐CPB                              7.6             1.8              15.7               4.5      15.5        4.0                   5.00                    0.031                    0.061     0.046     0.999
  Blood lactate concentration, mmol/L                                                                                                                                                                       
  Pre‐CPB                               1.4             0.4              1.3                0.5      1.6         0.4                   0.50                    0.618                                        
  Pre‐FF/CA                             1.5             0.5              2.2                1.0      2.7         0.5                   3.03                    0.094                                        
  Post‐FF/CA                            1.9             1.1              1.3                0.8      6.6         1.6                   23.24                   \<0.001                  0.999     0.002     0.000
  Post‐CPB                              2.2             1.0              1.4                0.7      5.0         1.4                   12.76                   0.002                    0.999     0.022     0.002
  Total NDS (day 1‐3)                   0.0             0.0              35.0               30.0     280.8       74.4                  36.53                   \<0.001                  0.999     \<0.001   \<0.001
  Total OPC (day 1‐3)                   3.0             0.0              4.0                1.2      7.8         1.0                   34.19                   \<0.001                  0.581     \<0.001   \<0.001

CA indicates circulatory arrest; CPB, cardiopulmonary bypass; FF, full‐flow perfusion; NDS, neuronal deficit score; OPC, overall performance category; Pa[co]{.smallcaps} ~2~, partial pressure of carbon dioxide; Pa[o]{.smallcaps} ~2~, partial pressure of oxygen.

Diffusion Tensor Imaging {#jah32429-sec-0013}
------------------------

Conventional anatomical T1 and T2 MRI and DTI images were acquired on a GE Signa HDxt 3.0T scanner (GE Medical Systems, Milwaukee, WI) using a GE Quad Knee coil. Prior to DTI measurement, we acquired conventional coronal and axial T2‐weighted fast spin‐echo T2 fluid attenuation inversion recovery (FLAIR), and T1‐weighted FLAIR imaging sequences with the following parameters: axial T1 FLAIR, echo time (TE)=7 ms, recovery time (TR)=3000 ms, inversion recovery time (TIR)=1238ms, echo train length=7, matrix=256×128, 3‐mm slice, 2 average; axial T2 fast spin‐echo, TE=90 ms, TR=2200 ms, echo train length=25, matrix=256×128, 3‐mm slice, 8 average; axial T2 FLAIR, TE=96 ms, TR=6000 ms, TIR=2400 ms, matrix=256×128, 3‐mm slice, 2 average; coronal T1 FLAIR, TE=9 ms, TR=3000 ms, TIR=1238 ms, echo train length=7, matrix=320×224, 3‐mm slice, 1 average; coronal T2 fast spin‐echo, TE=90 ms, TR=4000 ms, echo train length=25, matrix=256×128, 3‐mm slice, 8 average; and coronal T2 FLAIR, TE=90 ms, TR=6000 ms, TIR=2400 ms, matrix=256×128, 2‐mm slice, 2 average. DTI data were obtained using a single‐shot spin echo (SE) echoplanar imaging axial DTI sequence with the following parameters: TE=102.5 ms, TR=6000 ms, matrix=128×128, 4‐mm slice, 1 reference plus 15 directions with diffusion weighting (b=1000 s/mm^2^) with 8 average. All animals were sedated with intramuscular ketamine and xylazine before imaging. Anesthesia was maintained by isoflurane. Intravenous fluid was administered via the venous line during entire imaging experiment. The status of anesthesia and hemodynamics was continuously monitored by an MRI‐compatible monitoring system (Invivo Co, Orlando, FL). The MR images were transferred offline and reviewed by an MR physicist and a neuroradiologist. We performed a total of 40 MRI studies (pre‐CPB, n=13; post‐CPB day 3, n=13; post‐CPB day 10, n=4; post‐CPB day 17, n=1; week 4, n=9). Within a total of 40 imaging experiments, 5 experiments were excluded from our analysis (inadequate image quality n=4, different time point for preliminary analysis n=1). Among 35 imaging studies analyzed, a total of 10 experiments were performed preoperatively (Figure [1](#jah32429-fig-0001){ref-type="fig"}A). We also analyzed 13 and 9 imaging studies on post‐operative day 3 (control n=3, mild‐CPB n=4, and severe‐CPB n=6) and week 4 (control n=3, mild‐CPB n=3, severe‐CPB n=3), respectively (Figure [1](#jah32429-fig-0001){ref-type="fig"}A). To assess normal FA changes in porcine WM, data obtained from preoperative studies (3 weeks of age; n=10) as well as in controls on postoperative week 4 (7 weeks of age, n=3) were analyzed. Three additional MRI imaging studies were performed on postoperative day 10 to define changes of FA after severe‐CPB (Figure [1](#jah32429-fig-0001){ref-type="fig"}A). DTI data were processed using GE FuncTool software (Waukesha, WI). To avoid issues associated with spatial normalization of WM tracts, we applied a region‐of‐interest (ROI) approach to test specific structures throughout the brain selected in an a priori knowledge fashion. Free‐form polygon ROIs were identified using anatomical images and directionally encoded color FA maps. All ROIs were drawn and quantified manually using MIPAV freeware (NIH, Bethesda, MD). The anatomical locations of ROIs are described in the directionally encoded color map using ex vivo imaging methods in Figure [1](#jah32429-fig-0001){ref-type="fig"}B. Brains in the skull were isolated by removal at the first vertebra and removing the jaw up to the soft palate. Skulls were then incubated in 4% paraformaldehyde overnight followed by 1 week in 1% paraformaldehyde followed by 2 weeks in PBS all on a rocker at 4°C. Skulls were taken out and allowed to come to room temperature for at least 6 hours before imaging. The images were acquired on a Bruker BioSpin 7.0T scanner (Bruker BioSpin Corporation, Billerica, MA) in a Bruker 72‐mm volume coil. Two DTI echoplanar imaging scans were acquired with a TE=34.44 ms, and TR=700 ms. A total of 30 diffusion sampling directions were acquired along with 5 images with 0 diffusion (b=2500 s/mm^2^). Images were acquired in 3 dimensions with an isotropic voxel size of 0.5078 mm per side. A structural multiecho TurboRare T2 image with a TR of 700 and TEs of 34, 124.66, 215.33, and 305.99 ms, rare factor of 8, and 2 averages was also acquired. Tolerably Obsessive Registration and Tensor Optimization Indolent Software Ensemble (TORTOISE) was used to account for echoplanar imaging and eddy current distortion and to process directionally encoded color maps.[34](#jah32429-bib-0034){ref-type="ref"} A total of 31 WM structures in a porcine brain (Table [2](#jah32429-tbl-0002){ref-type="table-wrap"}) were constructed based on the DTI‐based human brain WM (DTI studio: Susumu Mori, Johns Hopkins University).[35](#jah32429-bib-0035){ref-type="ref"} Within a total of 88 human WM structures, superior corona radiata was subdivided into medial periventricular white matter (M‐PVWM) and lateral periventricular white matter (L‐PVWM) because of the significant developmental differences obtained from our previous immunohistochemistrical analysis using the porcine developmental model (Table [2](#jah32429-tbl-0002){ref-type="table-wrap"}).[22](#jah32429-bib-0022){ref-type="ref"} Each structure was further categorized based on (1) the deep or superficial WM, (2) type of fiber, and (3) 6 subdivisions (Table [2](#jah32429-tbl-0002){ref-type="table-wrap"}). FA is a scalar value between 0 and 1 that describes the degree of anisotropy of water diffusion processes in tissues.[14](#jah32429-bib-0014){ref-type="ref"} An FA value of 0 means that water diffusion is isotropic, ie, is unrestricted (or equally restricted) in all directions, whereas an FA value of 1 means water diffusion is unidirectional.[14](#jah32429-bib-0014){ref-type="ref"} WM volume in each distinct follow‐up group confirmed the minimum variation of drawn ROI volumes (Table [3](#jah32429-tbl-0003){ref-type="table-wrap"}), demonstrating the reliability of our FA measurement. Two observers blindly measured FA in 16 analyzed WM structures. The intraobserver correlation indicated strong agreement (Figure [2](#jah32429-fig-0002){ref-type="fig"}A).

###### 

Distinguished Porcine White Matter Structures

  Abbreviation   Structure                                                        Deep/Superficial White Matter   Fiber Category   Subdivision
  -------------- ---------------------------------------------------------------- ------------------------------- ---------------- -----------------------------------
  GCC            Genu of corpus callosum                                          Deep white matter               Commissural      Corpus callosum
  BCC            Body of corpus callosum                                          Deep white matter               Commissural      Corpus callosum
  SCC            Splenium of corpus callosum                                      Deep white matter               Commissural      Corpus callosum
  ALIC           Anterior limb of internal capsule                                Deep white matter               Projection       Internal capsule
  PLIC           Posterior limb of internal capsule                               Deep white matter               Projection       Internal capsule
  RLIC           Retrolenticular part of internal capsule                         Deep white matter               Projection       Internal capsule
  M‐PVWM         Medial periventricular white matter (superior corona radiata)    Deep white matter               Projection       Distant projection
  L‐PVWM         Lateral periventricular white matter (superior corona radiata)   Deep white matter               Projection       Distant projection
  PTR            Posterior thalamic radiation                                     Deep white matter               Projection       Distant projection
  SLF            Superior longitudinal fasciculus                                 Deep white matter               Association      Deep white matter association
  CingWM         Cingulum white matter                                            Deep white matter               Association      Deep white matter association
  SFWM           Superior frontal white matter                                    Superficial white matter        Association      Frontal superficial white matter
  MFWM           Middle frontal white matter                                      Superficial white matter        Association      Frontal superficial white matter
  IFWM           Inferior frontal white matter                                    Superficial white matter        Association      Frontal superficial white matter
  PrCWM          Precentral white matter                                          Superficial white matter        Association      Parietal superficial white matter
  SPWM           Superior parietal white matter                                   Superficial white matter        Association      Parietal superficial white matter

###### 

White Matter ROI Volumes

  WM Regions   Pre‐CPB (n=10)   Day 3 (n=13)   Week 4 (n=9)                                              
  ------------ ---------------- -------------- -------------- -------- ------- -------- -------- ------- --------
  GCC          7.111            1.942          27.305         7.225    1.416   19.596   7.349    2.108   28.684
  BCC          5.187            0.566          10.916         5.100    1.270   24.900   5.711    1.472   25.765
  SCC          7.826            1.609          20.557         7.939    1.138   14.332   8.540    1.929   22.587
  ALIC         12.321           3.174          25.759         12.363   2.549   20.616   12.816   2.105   16.427
  PLIC         19.064           3.129          16.412         18.346   3.194   17.413   21.331   3.198   14.994
  RLIC         16.064           3.645          21.337         14.446   3.428   25.232   18.613   3.023   16.243
  M‐PVWM       4.214            1.126          26.732         4.121    0.914   22.180   4.313    1.096   25.411
  L‐PVWM       6.588            0.977          27.756         7.445    1.829   37.700   6.830    2.807   28.424
  PTR          13.770           3.316          24.085         13.593   2.736   20.130   16.431   3.473   21.135
  SLF          9.554            2.570          26.895         8.832    0.930   10.535   10.116   1.813   17.925
  CingWM       8.404            1.738          20.682         8.462    2.652   31.342   10.033   1.795   17.894
  SFWM         13.375           2.134          15.957         13.164   1.672   12.700   14.005   2.871   20.497
  MFWM         12.684           1.382          10.897         14.055   2.411   17.153   15.434   3.005   19.472
  IFWM         9.397            2.551          27.148         10.076   1.620   16.074   11.145   2.050   18.391
  PrCWM        8.344            1.240          14.864         7.791    1.243   15.955   10.163   3.294   32.417
  SPWM         8.979            2.829          31.506         8.271    1.695   20.497   10.177   1.915   18.822

ALIC indicates anterior limb of the internal capsule; BCC, body of the corpus callosum; CingWM, cingulum white matter; CPB, cardiopulmonary bypass; CV, coefficient of variation; FA, fractional anisotropy; GCC, genu of the corpus callosum; IFWM, inferior frontal white matter; L‐PVWM, lateral periventricular white matter; MFWM, middle frontal white matter; M‐PVWM, medial periventricular white matter; PLIC, posterior limb of the internal capsule; PrCWM, precentral white matter; PTR, posterior thalamic radiation; RLIC, retrolenticular limb of the internal capsule; ROI, region of interest; SCC, splenium of the corpus callosum; SFWM, superior frontal white matter; SLF, superior longitudinal fasciculus; SPWM, superior‐parietal white matter; WM, white matter.

![The piglet brain is a powerful model to study human white matter (WM) development. A, Intraobserver correlation of FA analyzed using ROI measurements from diffusion tensor images by the Spearman rank‐order correlation coefficient (16 WM structures analyzed). B, FA in the deep WM of the pig is significantly higher than in superficial WM at 3 and 7 weeks of age, as observed in human WM (3 weeks, n=10; 7 weeks, n=3). More data are presented in Table [4](#jah32429-tbl-0004){ref-type="table-wrap"}. C, Consistent with findings in human WM development, FA in porcine WM is highest in projection fibers and lowest in association fibers at each age (3 weeks, n=10 in each; 7 weeks, n=3 in each). More data are presented in Table [4](#jah32429-tbl-0004){ref-type="table-wrap"}. D, Plot of FA in 6 porcine WM subregions at 3 weeks of age, and the change from 3 to 7 weeks demonstrates a structure‐specific maturation pattern similar to human WM development (3 weeks, n=10 in each; 7 weeks, n=3 in each). More data are presented in Table [4](#jah32429-tbl-0004){ref-type="table-wrap"}. FA indicates fractional anisotropy; ROI, region of interest.](JAH3-6-e005997-g002){#jah32429-fig-0002}

Immunohistochemistry {#jah32429-sec-0014}
--------------------

Before being postfixed for an additional 24 hours at 4°C in 4% paraformaldehyde, the brain was separated into sections. The sections were soaked for 24 hours in 15% sucrose in phosphate‐buffered saline, pH 7.4, followed by 48 hours in 30% sucrose in phosphate‐buffered saline, pH 7.4. All samples were embedded in OCT compound, sliced with a cryostat at −20°C, and stored at −80°C until immunohistochemical processing. Twenty‐micrometer sections were incubated for 1 hour at room temperature with blocking solution (20% normal goat serum, 1% bovine serum albumin, and 0.3% Tween 20 in phosphate‐buffered saline, pH 7.4) and then incubated at 4°C overnight with primary antibody and carrier solution (2% normal goat serum, 2% bovine serum albumin, and 0.3% Tween 20 in phosphate‐buffered saline, pH 7.4). Species‐specific secondary fluorescent antibodies (1:200; Jackson ImmunoResearch Laboratories, Inc, West Grove, PA) were diluted in carrier solution and applied to sections for 1 hour at room temperature. Sections were mounted with VECTASHIELD mounting medium for fluorescence with 4′,6‐diamidino‐2‐phenylindole (Vector Laboratories, Inc, Burlingame, CA). The following antibodies were used for immunohistochemistry: anti‐Olig2 (1:1000; Millipore, Billerica, MA), anti‐CC1 (1:1000; Millipore), anti‐Glial Fibrillary Acidic Protein (GFAP) (1:1000; DAKO, Santa Clara, CA), anti‐Glutamine Synthetase (GS) (1:1000; Millipore), and anti‐Iba1 (1:1000; Wako Chemicals, Richmond, VA). Cellular analysis was performed in the coronal section including 7 WM regions: (1) body of corpus callosum (BCC); (2) medial‐periventricular WM (M‐PVWM); (3) lateral‐periventricular WM (L‐PVWM); (4) anterior limb of internal capsule; (5) superior frontal WM (SFWM); (6) middle frontal WM (MFWM); and (7) inferior frontal WM (IFWM). Porcine oligodendrocyte lineage cells and mature oligodendrocyte were identified by antibodies to Olig2 and CC1.[36](#jah32429-bib-0036){ref-type="ref"}, [37](#jah32429-bib-0037){ref-type="ref"} An Iba1 antibody was used to identify microglia. Astrocytes were determined by antibodies to GFAP and GS. Images were acquired on a Zeiss LSM 510 confocal microscope (Carl Zeiss Microimaging LLC, Thornwood, NY). A stereology microscope (Stereo Investigator, MBF Bioscience, Williston, VT) was used to define antibody‐positive cell density. The Stereo Investigator system provides systematic random sampling to obtain unbiased estimates of cell number.[38](#jah32429-bib-0038){ref-type="ref"}

Statistical Analysis {#jah32429-sec-0015}
--------------------

The Kolmogorov‐Smirnov goodness‐of‐fit test of normality was performed to assess whether variables followed a normal (Gaussian‐shaped) distribution. The Student t test was performed to compare FA values between 3 and 7 weeks of age in normal development and 2 CPB conditions after surgery. We used one‐way analysis of variance (ANOVA) with Bonferroni post hoc comparisons to compare perioperative variables and FA in each WM ROI among 3 CPB conditions. Two‐way ANOVA with Bonferroni comparisons with WM ROIs treated as a factor was performed to evaluate changes in FA and cell number for WM regions among 3 CPB groups. We applied 2‐way ANOVA with Bonferroni post hoc comparisons with time as a factor to evaluate (1) changes in FA under normal physiological development and (2) changes in cell number after severe CPB between WM ROIs. Factorial 2‐way ANOVA (rather than repeated‐measures ANOVA) was applied for the assessment because of the exclusion of some imaging data due to the inadequate quality and factorial experimental design in the cellular assay. To determine the association of cellular events on changes of FA for each WM ROI, we first applied linear regression methods and analyzed the relationships separately for each distinct group. Linear trend between 2 groups was tested in the model. Relationships between FA values and antibody‐positive cell numbers were analyzed using nonparametric tests including the Mann‐Whitney U‐test, Kruskal‐Wallis H‐test with multiple‐comparison procedure[39](#jah32429-bib-0039){ref-type="ref"} and the Spearman rank‐order correlation coefficient (*r* ~s~). Previous studies demonstrated that cellular maturation in the human WM involves expansion of oligodendrocyte lineages and axonal myelination by mature oligodendrocytes followed by a decline of mature oligodendrocytes.[37](#jah32429-bib-0037){ref-type="ref"}, [40](#jah32429-bib-0040){ref-type="ref"}, [41](#jah32429-bib-0041){ref-type="ref"} Based on previous evidence regarding cellular processes underlying WM maturation, a Gaussian equation (Gauss‐Newton) was applied to nonlinear regression model in control WM and was based on ordinary least squares for minimizing the sum of the squared residuals to derive the best‐fitting curve to the data.[42](#jah32429-bib-0042){ref-type="ref"} Nonlinear regression weighted each point equally in describing the curvilinear relationship between Olig2‐positive cells and FA. Our nonlinear method aimed to reduce the sum of the squared errors by assuming that the least‐squares function was locally quadratic and then finding the minimum of the quadratic curve (ie, the objective function is approximately quadratic). Because the model was applied to all data at 7 weeks of age (ie, no range of time points), thresholds of the range were not determined for the fitted regression model. With the nonlinear regression method, fit statistics and R^2^ values between FA values and Olig2‐positive cell numbers were estimated. To ascertain the effects of mature oligodendrocyte and microglia cell numbers on FA reduction, we used logistic regression analysis in which we examined cutoff values and defined the binary outcomes as a reduction of 1 SD below the mean FA for the controls for each WM structure. Receiver‐operating characteristic curve analysis with the Youden J‐index was applied to ascertain the predictive accuracy between CPB‐induced FA reduction and change in number of mature oligodendrocytes relative to control. Probability curves were derived by maximum‐likelihood estimation in logistic regression to illustrate FA reduction as a function of the changes in oligodendrocytes and microglia number relative to control on post‐CPB. Statistical analysis was performed using the PRISM6 software package (GraphPad Software, Inc, La Jolla, CA) and IBM SPSS Statistics Version 23.0 (IBM Corporation, Armonk, NY).

Results {#jah32429-sec-0016}
=======

The Structure‐Specific Maturation Pattern in the Porcine Model Is Similar to Human WM Development, and WM Development in the Postnatal Porcine Brain Represents Early Infancy in Human WM {#jah32429-sec-0017}
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

In our porcine developmental model, FA values were significantly different among tested WM structures (F=34.5, *P*\<0.001) and at ages 3 weeks versus 7 weeks (F=72.4, *P*\<0.001). The means and standard deviations for each structure in 2 age groups are given in Table [4](#jah32429-tbl-0004){ref-type="table-wrap"}. FA in the deep WM was significantly higher than those in superficial WM in both age groups (Figure [2](#jah32429-fig-0002){ref-type="fig"}B). Within 3 fiber categories consisting of commissural, projection, and association fibers, FA was highest in projection fibers and lowest in association fibers at each age (Figure [2](#jah32429-fig-0002){ref-type="fig"}C). These observations are consistent with findings in a structure‐specific maturation pattern to human WM development.[43](#jah32429-bib-0043){ref-type="ref"}, [44](#jah32429-bib-0044){ref-type="ref"}, [45](#jah32429-bib-0045){ref-type="ref"} The porcine WM showed asymmetric diffusion properties at each age group, and the developmental pattern was also asymmetric (Table [4](#jah32429-tbl-0004){ref-type="table-wrap"}). FA asymmetry and hemispheric lateralization have been widely observed in the human brain and are important in neurological function.[43](#jah32429-bib-0043){ref-type="ref"}, [46](#jah32429-bib-0046){ref-type="ref"} When we plot FA values at postnatal 3 weeks and the changes from 3 to 7 weeks, corpus callosum (CC) has the largest FA change (19.5%) among 6 representative WM regions (Figure [2](#jah32429-fig-0002){ref-type="fig"}D), as observed in human neonates.[43](#jah32429-bib-0043){ref-type="ref"} Within superficial WM structures, the increase in FA in frontal WM (18.4%) was larger than that in parietal regions (Figure [2](#jah32429-fig-0002){ref-type="fig"}D). This has also been identified in human neonatal and pediatric DTI.[44](#jah32429-bib-0044){ref-type="ref"} The internal capsule (IC) had the highest FA value at 3 weeks among distinguished porcine WM structures (Figure [2](#jah32429-fig-0002){ref-type="fig"}D). In particular, the highest ranges of FA values were observed in the posterior limb of the IC (PLIC) and the retrolenticular part of the IC compared with other structures (Table [4](#jah32429-tbl-0004){ref-type="table-wrap"}). In the human WM at 40 postconceptional weeks, FA values of the PLIC were the highest compared with other regions.[45](#jah32429-bib-0045){ref-type="ref"} Consistent with our previous findings using an immunohistological approach,[22](#jah32429-bib-0022){ref-type="ref"} our imaging studies indicate that porcine WM development displays a structure‐specific maturation pattern similar to that of human WM.

###### 

Comparison of Fractional Anisotropy Between Age Groups Stratified by WM Region

                   3 Weeks   7 Weeks   *P* Value           
  ---------------- --------- --------- ----------- ------- ------------------------------------------------
  Deep WM          n=10                n=3                 
  GCC              0.314     0.048     0.406       0.091   0.025[a](#jah32429-note-0170){ref-type="fn"}
  BCC                                                      
  Mean             0.365     0.046     0.407       0.010   0.148
  Left             0.380     0.055     0.421       0.044   0.256
  Right            0.349     0.047     0.393       0.030   0.147
  SCC                                                      
  Mean             0.320     0.037     0.380       0.067   0.049[a](#jah32429-note-0170){ref-type="fn"}
  Left             0.313     0.038     0.395       0.051   0.008[a](#jah32429-note-0170){ref-type="fn"}
  Right            0.327     0.041     0.365       0.083   0.258
  ALIC                                                     
  Mean             0.415     0.032     0.511       0.040   \<0.001[a](#jah32429-note-0170){ref-type="fn"}
  Left             0.413     0.036     0.494       0.035   0.004[a](#jah32429-note-0170){ref-type="fn"}
  Right            0.418     0.035     0.528       0.045   \<0.001[a](#jah32429-note-0170){ref-type="fn"}
  PLIC                                                     
  Mean             0.458     0.040     0.517       0.024   0.031[a](#jah32429-note-0170){ref-type="fn"}
  Left             0.452     0.039     0.525       0.034   0.012[a](#jah32429-note-0170){ref-type="fn"}
  Right            0.464     0.046     0.509       0.014   0.129
  RLIC                                                     
  Mean             0.505     0.044     0.495       0.046   0.717
  Left             0.483     0.065     0.502       0.048   0.651
  Right            0.528     0.035     0.488       0.048   0.124
  M‐PVWM                                                   
  Mean             0.375     0.033     0.428       0.010   0.019[a](#jah32429-note-0170){ref-type="fn"}
  Left             0.378     0.037     0.454       0.030   0.006[a](#jah32429-note-0170){ref-type="fn"}
  Right            0.371     0.037     0.403       0.014   0.179
  L‐PVWM                                                   
  Mean             0.439     0.043     0.479       0.009   0.140
  Left             0.437     0.049     0.487       0.011   0.112
  Right            0.441     0.048     0.472       0.027   0.312
  PTR                                                      
  Mean             0.445     0.039     0.509       0.010   0.016[a](#jah32429-note-0170){ref-type="fn"}
  Left             0.421     0.038     0.493       0.026   0.009[a](#jah32429-note-0170){ref-type="fn"}
  Right            0.470     0.048     0.526       0.019   0.072
  SLF                                                      
  Mean             0.303     0.033     0.325       0.025   0.326
  Left             0.309     0.033     0.326       0.037   0.473
  Right            0.297     0.038     0.323       0.014   0.278
  CingWM                                                   
  Mean             0.302     0.032     0.353       0.013   0.022[a](#jah32429-note-0170){ref-type="fn"}
  Left             0.285     0.038     0.342       0.013   0.027[a](#jah32429-note-0170){ref-type="fn"}
  Right            0.319     0.036     0.364       0.027   0.065
  Superficial WM   n=10                n=3                 
  SFWM                                                     
  Mean             0.300     0.022     0.342       0.017   0.009[a](#jah32429-note-0170){ref-type="fn"}
  Left             0.299     0.022     0.343       0.022   0.009[a](#jah32429-note-0170){ref-type="fn"}
  Right            0.300     0.024     0.341       0.012   0.014[a](#jah32429-note-0170){ref-type="fn"}
  MFWM                                                     
  Mean             0.288     0.045     0.354       0.021   0.032[a](#jah32429-note-0170){ref-type="fn"}
  Left             0.311     0.053     0.368       0.026   0.103
  Right            0.264     0.062     0.340       0.022   0.063
  IFWM                                                     
  Mean             0.339     0.034     0.401       0.006   0.009[a](#jah32429-note-0170){ref-type="fn"}
  Left             0.351     0.034     0.398       0.016   0.041[a](#jah32429-note-0170){ref-type="fn"}
  Right            0.327     0.045     0.404       0.010   0.013[a](#jah32429-note-0170){ref-type="fn"}
  PrCWM                                                    
  Mean             0.305     0.037     0.339       0.032   0.161
  Left             0.310     0.040     0.357       0.035   0.092[a](#jah32429-note-0170){ref-type="fn"}
  Right            0.299     0.040     0.321       0.031   0.038[a](#jah32429-note-0170){ref-type="fn"}
  SPWM                                                     
  Mean             0.265     0.031     0.316       0.013   0.018[a](#jah32429-note-0170){ref-type="fn"}
  Left             0.256     0.030     0.312       0.030   0.013[a](#jah32429-note-0170){ref-type="fn"}
  Right            0.275     0.039     0.320       0.026   0.088

FA values are significantly different among WM regions analyzed (F=34.5, *P*\<0.001) and at ages 3 weeks vs 7 weeks (F=72.4, *P*\<0.001) by 2‐way ANOVA. ALIC indicates anterior limb of the internal capsule; BCC, body of the corpus callosum; CingWM, cingulum white matter; FA, fractional anisotropy; GCC, genu of the corpus callosum; IFWM, inferior frontal white matter; L‐PVWM, lateral periventricular white matter; MFWM, middle frontal white matter; M‐PVWM, medial periventricular white matter; PLIC, posterior limb of the internal capsule; PrCWM, pre‐central white matter; PTR, posterior thalamic radiation; RLIC, retrolenticular limb of the internal capsule; SCC, splenium of the corpus callosum; SFWM, superior frontal white matter; SLF, superior longitudinal fasciculus; SPWM, superior‐parietal white matter; WM, white matter.

*P*\<0.05.

A lack of cellular investigations in postnatal human brain due to technical and ethical difficulties has prevented the definition of epochs of human WM development that correspond to the porcine model.[22](#jah32429-bib-0022){ref-type="ref"} Oishi et al performed normalization‐based brain analysis with detailed anatomic information derived from DTI in human neonates, which demonstrated age‐dependent and structure‐specific FA changes with different slopes and intercepts.[45](#jah32429-bib-0045){ref-type="ref"} In their study, the FA slope was the highest in the PLIC.[45](#jah32429-bib-0045){ref-type="ref"} The FA of the PLIC in this animal model displays 0.458±0.040 and 0.517±0.024 at 3 and 7 weeks of age, respectively (Table [4](#jah32429-tbl-0004){ref-type="table-wrap"}). Using regression analysis (FA=0.0063×age+0.162), we identified that FA value in the same porcine WM structure at postnatal 3 and 7 weeks was equivalent to those of human postconceptional 41 to 53 and 53 to 60 weeks, respectively, indicating that developmental time windows in this model correspond with early infancy in human WM. Studies of postmortem human tissue are limited, particularly for analysis of perinatal brain development under normal physiological conditions. Although nonhuman primates share key structural characteristics of the human gyrencephalic WM, technical and ethical barriers often prevent direct investigations in these species, especially during early infancy. Thus, our results demonstrate that the postnatal porcine brain is a powerful tool to study normal development and its pathology in the human neonate and infant WM.

Developmental Stage‐Dependent WM Vulnerability Against Insults Associated With Congenital Heart Surgery {#jah32429-sec-0018}
-------------------------------------------------------------------------------------------------------

Using the model, we next assessed FA changes on postoperative day 3 and week 4 following CPB (Figure [1](#jah32429-fig-0001){ref-type="fig"}A). FA values on post‐CPB day 3 were significantly different among tested WM structures but not among 3 CPB groups (Table [5](#jah32429-tbl-0005){ref-type="table-wrap"}). On the other hand, at 4 weeks after surgery both WM structures and CPB groups had significant differences in FA values (Table [5](#jah32429-tbl-0005){ref-type="table-wrap"}). We also found significant interaction between WM regions and CPB groups on postoperative week 4 (Table [5](#jah32429-tbl-0005){ref-type="table-wrap"}). The interactions among 6 WM subregions and CPB groups in FA value at 4 weeks after surgery are given in Figure [3](#jah32429-fig-0003){ref-type="fig"}A. The decrease in FA after CPB was significantly identified in the CC, followed by the frontal superior WM (Figure [3](#jah32429-fig-0003){ref-type="fig"}A, Table [6](#jah32429-tbl-0006){ref-type="table-wrap"}). These regions displayed the largest FA change from postnatal 3 to 7 weeks in normal porcine WM development (Figure [2](#jah32429-fig-0002){ref-type="fig"}D). In contrast, the IC and distant projection (DP), which had different DTI characteristics in normal physiological condition including high FAs at 3 weeks of age and low changes from 3 to 7 weeks (Figure [2](#jah32429-fig-0002){ref-type="fig"}D), demonstrated no changes at 4 weeks after CPB compared with control (Figure [3](#jah32429-fig-0003){ref-type="fig"}A). These results confirm developmental stage‐dependent WM vulnerability to brain insults, as shown in studies using rodent and large animal models.[47](#jah32429-bib-0047){ref-type="ref"}, [48](#jah32429-bib-0048){ref-type="ref"}

###### 

Fractional Anisotropy in Each WM Region on Postoperative Day 3 and Week 4

  CPB Groups                                      Control   Mild CPB   Severe CPB   F Test   *P* Value   Control vs Mild CPB   Control vs Severe CPB   Mild CPB vs Severe CPB                   
  ----------------------------------------------- --------- ---------- ------------ -------- ----------- --------------------- ----------------------- ------------------------ ------- ------- -------
  Day 3[a](#jah32429-note-0005){ref-type="fn"}    n=3                  n=4                   n=6                                                                                                
  GCC                                             0.291     0.025      0.315        0.078    0.350       0.037                 1.458                   0.272                                    
  BCC                                             0.370     0.037      0.380        0.036    0.372       0.025                 0.116                   0.892                                    
  SCC                                             0.291     0.030      0.327        0.032    0.327       0.029                 1.615                   0.247                                    
  ALIC                                            0.426     0.015      0.439        0.042    0.440       0.047                 0.131                   0.879                                    
  PLIC                                            0.473     0.010      0.475        0.056    0.469       0.026                 0.111                   0.896                                    
  RLIC                                            0.530     0.036      0.442        0.102    0.489       0.026                 1.830                   0.210                                    
  M‐PVWM                                          0.375     0.035      0.385        0.035    0.427       0.035                 2.882                   0.103                                    
  L‐PVWM                                          0.449     0.039      0.456        0.048    0.461       0.029                 0.104                   0.903                                    
  PTR                                             0.437     0.016      0.432        0.041    0.458       0.029                 0.979                   0.409                                    
  SLF                                             0.315     0.038      0.298        0.031    0.301       0.032                 0.238                   0.793                                    
  CingWM                                          0.282     0.021      0.299        0.018    0.319       0.030                 2.318                   0.149                                    
  SFWM                                            0.303     0.021      0.303        0.031    0.316       0.041                 0.231                   0.798                                    
  MFWM                                            0.303     0.037      0.295        0.050    0.271       0.060                 0.465                   0.641                                    
  IFWM                                            0.360     0.031      0.337        0.026    0.331       0.062                 0.363                   0.704                                    
  PrCWM                                           0.339     0.005      0.307        0.046    0.283       0.015                 4.101                   0.050                    0.157   0.017   0.219
  SPWM                                            0.260     0.006      0.260        0.051    0.279       0.039                 0.393                   0.685                                    
  Week 4[b](#jah32429-note-0006){ref-type="fn"}   n=3                  n=3                   n=3                                                                                                
  GCC                                             0.406     0.091      0.424        0.026    0.260       0.023                 7.741                   0.022                    0.705   0.019   0.012
  BCC                                             0.407     0.010      0.451        0.038    0.343       0.029                 11.249                  0.009                    0.106   0.031   0.003
  SCC                                             0.380     0.067      0.373        0.047    0.331       0.040                 0.770                   0.504                                    
  ALIC                                            0.511     0.040      0.478        0.028    0.482       0.022                 1.019                   0.416                                    
  PLIC                                            0.517     0.024      0.516        0.003    0.510       0.025                 0.117                   0.891                                    
  RLIC                                            0.495     0.046      0.553        0.003    0.518       0.057                 1.439                   0.309                                    
  M‐PVWM                                          0.428     0.010      0.404        0.033    0.412       0.086                 0.160                   0.855                                    
  L‐PVWM                                          0.479     0.009      0.513        0.026    0.496       0.015                 2.669                   0.148                                    
  PTR                                             0.509     0.010      0.482        0.023    0.485       0.061                 0.464                   0.650                                    
  SLF                                             0.325     0.025      0.310        0.016    0.311       0.038                 0.244                   0.791                                    
  CingWM                                          0.353     0.013      0.312        0.041    0.330       0.036                 1.229                   0.357                                    
  SFWM                                            0.342     0.017      0.374        0.005    0.319       0.008                 17.712                  0.003                    0.014   0.045   0.001
  MFWM                                            0.354     0.021      0.325        0.017    0.286       0.024                 7.971                   0.020                    0.136   0.007   0.065
  IFWM                                            0.401     0.006      0.298        0.008    0.353       0.084                 3.352                   0.105                                    
  PrCWM                                           0.339     0.032      0.308        0.011    0.315       0.017                 1.645                   0.269                                    
  SPWM                                            0.316     0.013      0.342        0.001    0.309       0.021                 4.562                   0.062                                    

ALIC indicates anterior limb of the internal capsule; BCC, body of the corpus callosum; CingWM, cingulum white matter; CPB, cardiopulmonary bypass; FA, fractional anisotropy; GCC, genu of the corpus callosum; IFWM, inferior frontal white matter; L‐PVWM, lateral periventricular white matter; MFWM, middle frontal white matter; M‐PVWM, medial periventricular white matter; PLIC, posterior limb of the internal capsule; PrCWM, precentral white matter; PTR, posterior thalamic radiation; RLIC, retrolenticular limb of the internal capsule; SCC, splenium of the corpus callosum; SFWM, superior frontal white matter; SLF, superior longitudinal fasciculus; SPWM, superior parietal white matter; WM, white matter.

FA values are significantly different among 16 WM regions (F=41.2, *P*\<0.001), but not between CPB groups (F=1.06, *P*=0.348) by 2‐way ANOVA.

FA values are significantly different among 16 WM regions (F=44.5, *P*\<0.001) and between CPB groups (F=10.8, *P*\<0.001) by 2‐way ANOVA. There are significant interactions between WM regions and CPB (F=2.39, *P*\<0.001).

![There is maturation‐dependent WM vulnerability following CPB. FA changes after CPB are also insult‐dependent. A, The decrease in FA after severe CPB is identified in the corpus callosum and the frontal superior WM, where the largest FA change from 3 to 7 weeks is observed in normal WM development (Figure [2](#jah32429-fig-0002){ref-type="fig"}D). FA in internal capsule and distant projection, which are characterized as mature WM regions with high FA and low changes (Figure [2](#jah32429-fig-0002){ref-type="fig"}D), demonstrates no changes following CPB, indicating maturation‐dependent WM vulnerability to insults associated with congenital heart surgery (n=3 in each). More data are presented in Table [5](#jah32429-tbl-0005){ref-type="table-wrap"}. B and C, Although there are no changes in FA on post‐CPB day 3, severe CPB results in significant FA decreases in BCC (B) and SFWM (C) 4 weeks postoperatively. A significant FA increase is also seen in SFWM (C) following mild CPB (n=3‐6 in each). More data are presented in Table [5](#jah32429-tbl-0005){ref-type="table-wrap"}. D through F, Percentage change of FA from preoperation displays a significant decrease in FA after severe CPB in the corpus callosum (D); on the other hand, mild CPB causes FA increase in the internal capsule and parietal superficial WM compared with control (E and F), demonstrating insult‐dependent FA alterations after cardiac surgery (n=3 in each). More data are presented in Table [8](#jah32429-tbl-0008){ref-type="table-wrap"}. \**P*\<0.05 vs other CPB groups by ANOVA with Bonferoni comparison, \*\**P*\<0.05, \*\*\**P*\<0.01 vs control by Student t test. Data are shown as mean±SEM. BCC indicates body of the corpus callosum; CPB, cardiopulmonary bypass; FA, fractional anisotropy. Pre, preoperation; SFWM, superior frontal white matter; WM, white matter.](JAH3-6-e005997-g003){#jah32429-fig-0003}

###### 

FA in Each WM Subregion on Postoperative Day 3 and Week 4

                                                  Control   Mild CPB   Severe CPB   F Test   *P* Value   Control vs Mild CPB   Control vs Severe CPB   Mild CPB vs Severe CPB                     
  ----------------------------------------------- --------- ---------- ------------ -------- ----------- --------------------- ----------------------- ------------------------ -------- -------- --------
  Day 3[a](#jah32429-note-0008){ref-type="fn"}    n=3                  n=4                   n=6                                                                                                  
  Corpus callosum                                 0.3170    0.0198     0.3405       0.0470   0.3498      0.0106                1.348                   0.3031                                     
  Internal capsule                                0.4762    0.0179     0.4521       0.0559   0.4663      0.0236                0.410                   0.6745                                     
  Distant projection                              0.4203    0.0056     0.4243       0.0366   0.4488      0.0233                1.648                   0.2407                                     
  Deep WM association                             0.2984    0.0187     0.2987       0.0099   0.3101      0.0263                0.476                   0.6345                                     
  Frontal superior WM                             0.3221    0.0248     0.3117       0.0343   0.3062      0.0459                0.166                   0.8492                                     
  Parietal superior WM                            0.2994    0.0053     0.2834       0.0486   0.2813      0.0205                0.377                   0.6956                                     
  Week 4[b](#jah32429-note-0009){ref-type="fn"}   n=3                  n=3                   n=3                                                                                                  
  Corpus callosum                                 0.3977    0.0539     0.4162       0.0370   0.3110      0.0109                6.469                   0.0318                   0.5755   0.0321   0.0151
  Internal capsule                                0.5075    0.0282     0.5158       0.0094   0.5030      0.0345                0.183                   0.8374                                     
  Distant projection                              0.4723    0.0032     0.4666       0.0275   0.4643      0.0532                0.043                   0.9584                                     
  Deep WM association                             0.3389    0.0186     0.3110       0.0290   0.3208      0.0365                0.716                   0.5260                                     
  Frontal superior WM                             0.3656    0.0138     0.3321       0.0066   0.3191      0.0379                3.095                   0.1193                                     
  Parietal superior WM                            0.3274    0.0131     0.3254       0.0055   0.3119      0.0090                2.255                   0.1861                                      

CPB indicates cardiopulmonary bypass; FA, fractional anisotropy; WM, white matter.

FA values are significantly different among 6 WM subregions (F=69.3, *P*\<0.001) but not among 3 CPB groups (F=0.58, *P*=0.564) by 2‐way ANOVA.

FA values are significantly different among 6 WM subregions (F=71.5, *P*\<0.001) and among 3 CPB groups (F=5.44, *P*\<0.01) by 2‐way ANOVA.

FA Changes After CPB are Both Region‐Specific and Insult‐Dependent and WM at Frontal Cortex is Susceptible to CPB‐Induced Insults {#jah32429-sec-0019}
---------------------------------------------------------------------------------------------------------------------------------

On postoperative week 4 (7 weeks of age), CPB significantly affected FA in 4 identified WM regions: GCC, BCC, SFWM, and MFWM (Table [5](#jah32429-tbl-0005){ref-type="table-wrap"}). On the other hand, no changes in apparent diffusion coefficient were displayed among 3 CPB groups at both day 3 and week 4 after surgery (Table [7](#jah32429-tbl-0007){ref-type="table-wrap"}). The time‐course of FA changes in BCC and SFWM on preoperative and postoperative day 3 and week 4 are also shown in Figure [3](#jah32429-fig-0003){ref-type="fig"}B and [3](#jah32429-fig-0003){ref-type="fig"}C. Severe CPB resulted in significant FA decreases in the corpus callosum (GCC, BCC) and subcortical WM of the frontal cortex (SFWM, MFWM) compared with control (Table [5](#jah32429-tbl-0005){ref-type="table-wrap"}). Interestingly a significant FA increase was seen in SFWM following mild CPB (Figure [3](#jah32429-fig-0003){ref-type="fig"}F). In GCC, BCC, and SFWM, FA was highest after mild CPB and lowest in severe CPB, and there was a significant difference between mild and severe CPB (Table [5](#jah32429-tbl-0005){ref-type="table-wrap"}). In our study design, mild CPB insult included CPB‐induced SIRS, whereas both SIRS and I/R injury were involved in severe CPB (Figure [1](#jah32429-fig-0001){ref-type="fig"}A and Table [1](#jah32429-tbl-0001){ref-type="table-wrap"}). Thus, our data suggest insult‐dependent FA alterations in developing WM following cardiac surgery.

###### 

Apparent Diffusion Coefficient in Each WM Region on Postoperative Day 3 and Week 4

  CPB Groups                                      Control   Mild CPB   Severe CPB   F Test   *P* Value                   
  ----------------------------------------------- --------- ---------- ------------ -------- ----------- ------- ------- -------
  Day 3[a](#jah32429-note-0011){ref-type="fn"}    n=3                  n=4                   n=6                         
  GCC                                             0.944     0.161      0.955        0.048    0.932       0.049   0.092   0.913
  BCC                                             1.059     0.067      0.948        0.116    0.968       0.081   1.434   0.284
  SCC                                             1.044     0.123      0.995        0.071    0.993       0.098   0.301   0.746
  ALIC                                            0.653     0.024      0.661        0.040    0.663       0.037   0.087   0.917
  PLIC                                            0.645     0.029      0.638        0.027    0.641       0.063   0.019   0.981
  RLIC                                            0.730     0.074      0.676        0.006    0.713       0.051   1.190   0.344
  M‐PVWM                                          0.734     0.023      0.677        0.042    0.664       0.059   2.178   0.164
  L‐PVWM                                          0.680     0.013      0.664        0.084    0.629       0.055   0.822   0.467
  PTR                                             0.774     0.029      0.753        0.035    0.788       0.039   1.178   0.347
  SLF                                             0.765     0.031      0.739        0.036    0.718       0.069   0.736   0.504
  CingWM                                          0.748     0.021      0.706        0.036    0.681       0.047   2.860   0.104
  SFWM                                            0.770     0.074      0.727        0.035    0.702       0.061   1.378   0.296
  MFWM                                            0.766     0.022      0.698        0.034    0.683       0.072   2.313   0.149
  IFWM                                            0.758     0.028      0.739        0.032    0.735       0.068   0.199   0.823
  PrCWM                                           0.709     0.020      0.698        0.035    0.680       0.071   0.321   0.733
  SPWM                                            0.759     0.025      0.734        0.059    0.716       0.057   0.682   0.528
  Week 4[b](#jah32429-note-0012){ref-type="fn"}   n=3                  n=3                   n=3                         
  GCC                                             0.853     0.126      0.856        0.130    0.908       0.113   0.191   0.831
  BCC                                             0.965     0.104      0.819        0.187    0.875       0.064   0.980   0.428
  SCC                                             0.907     0.093      0.904        0.153    0.923       0.018   0.029   0.972
  ALIC                                            0.670     0.040      0.638        0.070    0.666       0.028   0.379   0.700
  PLIC                                            0.652     0.045      0.587        0.099    0.644       0.046   0.803   0.491
  RLIC                                            0.708     0.055      0.668        0.042    0.704       0.020   0.817   0.486
  M‐PVWM                                          0.717     0.050      0.635        0.119    0.700       0.073   0.770   0.504
  L‐PVWM                                          0.712     0.047      0.580        0.105    0.661       0.049   2.552   0.158
  PTR                                             0.774     0.035      0.705        0.061    0.791       0.093   1.387   0.320
  SLF                                             0.797     0.047      0.680        0.133    0.779       0.114   1.093   0.394
  CingWM                                          0.772     0.086      0.652        0.147    0.724       0.074   0.961   0.435
  SFWM                                            0.741     0.053      0.670        0.099    0.715       0.020   0.879   0.463
  MFWM                                            0.725     0.046      0.749        0.128    0.711       0.064   0.148   0.866
  IFWM                                            0.800     0.042      0.654        0.148    0.772       0.074   1.836   0.239
  PrCWM                                           0.725     0.040      0.654        0.104    0.698       0.050   0.768   0.505
  SPWM                                            0.743     0.062      0.650        0.096    0.723       0.047   1.426   0.311

ALIC indicates anterior limb of the internal capsule; BCC, body of the corpus callosum; CingWM, cingulum white matter; CPB, cardiopulmonary bypass; GCC, genu of the corpus callosum; IFWM, inferior frontal white matter; L‐PVWM, lateral periventricular white matter; MFWM, middle frontal white matter; M‐PVWM, medial periventricular white matter; PLIC, posterior limb of the internal capsule; PrCWM, pre‐central white matter; PTR, posterior thalamic radiation; RLIC, retrolenticular limb of the internal capsule; SCC, splenium of the corpus callosum; SFWM, superior frontal white matter; SLF, superior longitudinal fasciculus; SPWM, superior‐parietal white matter; WM, white matter.

ADC values are significantly different among 16 WM regions (F=45.3, *P*\<0.0001) and between CPB groups (F=7.18, *P*\<0.01) by 2‐way ANOVA.

ADC values are significantly different among 16 WM regions (F=8.314, *P*\<0.001) and between CPB groups (F=9.031, *P*\<0.001) by 2‐way ANOVA.

We further analyzed percentage changes of FA from preoperation to week 4 postsurgery among 3 groups (Table [8](#jah32429-tbl-0008){ref-type="table-wrap"}). Within 16 WM areas, severe‐CPB significantly decreased FA in GCC, BCC, and MFWM (Table [8](#jah32429-tbl-0008){ref-type="table-wrap"}). These 3 regions had a large FA increase (17% to 24%) in control animals during the time period analyzed (Table [8](#jah32429-tbl-0008){ref-type="table-wrap"}). The results confirm the developmental stage‐dependent WM vulnerability to CPB‐induced insults. There were significant increases in FA after mild CPB in 4 WMs (PLIC, L‐PVWM, SFWM, and superior parietal WM) compared with control (Table [8](#jah32429-tbl-0008){ref-type="table-wrap"}). In superior parietal WM, severe CPB also resulted in FA increase (Table [8](#jah32429-tbl-0008){ref-type="table-wrap"}), suggesting that FA alteration following CPB varies among WM regions.

###### 

Percentage Change of Fractional Anisotropy in Each WM Region From Preoperative Period

  CPB Group   Control (n=3)   Mild CPB (n=3)   Severe CPB (n=3)   F Test   *P* Value   Control vs Mild CPB   Control vs Severe CPB   Mild CPB vs Severe CPB                   
  ----------- --------------- ---------------- ------------------ -------- ----------- --------------------- ----------------------- ------------------------ ------- ------- ---------
  GCC         24.034          27.780           38.258             8.435    −26.678     6.516                 11.844                  0.008                    0.350   0.011   0.004
  BCC         17.422          2.907            16.811             9.791    −7.725      7.822                 11.191                  0.009                    0.923   0.006   0.007
  SCC         8.170           19.079           22.157             15.463   −2.365      11.766                1.837                   0.239                                    
  ALIC        15.576          9.076            22.512             7.202    17.429      5.246                 0.718                   0.526                                    
  PLIC        7.580           4.993            21.934             0.651    9.564       5.418                 9.953                   0.012                    0.006   0.590   0.012
  RLIC        −0.780          9.249            13.370             0.568    5.517       11.651                2.041                   0.211                                    
  M‐PVWM      17.383          2.770            3.271              8.517    9.660       22.834                0.747                   0.513                                    
  L‐PVWM      5.237           2.074            25.127             6.302    10.902      3.291                 17.233                  0.003                    0.001   0.156   0.007
  PTR         5.775           2.087            18.799             5.769    7.095       13.361                2.140                   0.199                                    
  SLF         4.788           8.036            7.429              5.698    3.733       12.717                0.126                   0.884                                    
  CingWM      7.383           3.855            1.262              13.463   11.048      11.987                0.647                   0.556                                    
  SFWM        9.653           5.472            28.158             1.814    5.710       2.769                 31.610                  0.001                    0.001   0.239   \<0.001
  MFWM        21.757          7.353            21.203             6.317    −2.154      8.057                 10.550                  0.011                    0.929   0.007   0.008
  IFWM        10.648          1.709            −5.872             2.556    9.963       26.165                1.133                   0.383                                    
  PrCWM       8.168           10.154           10.834             3.909    7.098       5.727                 0.220                   0.808                                    
  SPWM        4.875           4.381            30.741             0.046    22.685      8.392                 17.594                  0.003                    0.001   0.007   0.121

FA values are significantly different among 16 WM regions (F=77.9, *P*\<0.001) and between CPB groups (F=2.5, *P*\<0.001) by 2‐way ANOVA. There are significant interactions between WM regions and CPB (F=8.3, *P*\<0.001). ALIC indicates anterior limb of the internal capsule; BCC, body of the corpus callosum; CingWM, cingulum white matter; CPB, cardiopulmonary bypass; FA, fractional anisotropy; GCC, genu of the corpus callosum; IFWM, inferior frontal white matter; L‐PVWM, lateral periventricular white matter; MFWM, middle frontal white matter; M‐PVWM, medial periventricular white matter; PLIC, posterior limb of the internal capsule; PrCWM, precentral white matter; PTR, posterior thalamic radiation; RLIC, retrolenticular limb of the internal capsule; SCC, splenium of the corpus callosum; SFWM, superior frontal white matter; SLF, superior longitudinal fasciculus; SPWM, superior parietal white matter; WM, white matter.

Within 6 WM subregions (Table [2](#jah32429-tbl-0002){ref-type="table-wrap"}), there were no differences in percentage changes in DP (*P*=0.53), deep WM association (*P*=0.92), and frontal superficial WM (*P*=0.32) among the 3 CPB groups. On the other hand, the corpus callosum displayed a significant decrease in FA after severe CPB (Figure [3](#jah32429-fig-0003){ref-type="fig"}D). In the IC and parietal superficial WM there were no differences between control and severe CPB, whereas mild CPB caused an FA increase compared with control (Figure [3](#jah32429-fig-0003){ref-type="fig"}E and [3](#jah32429-fig-0003){ref-type="fig"}F). Altogether our results demonstrated both region‐specific and insult‐dependent FA changes after cardiac surgery.

CPB‐Induced Cellular Events in the Developing WM Include an Increase in Oligodendrocyte Lineage Cells and Their Dysmaturation, Acute Astrogliosis, and Prolonged Microglial Expansion {#jah32429-sec-0020}
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

To understand cellular events associated with changes in WM anisotropy, we analyzed changes of major cellular components including Olig2^+^ oligodendrocyte lineage cells, Olig2^+^CC1^−^ immature oligodendrocytes, Olig2^+^CC1^+^ mature oligodendrocytes, Iba1^+^ microglia, and GS^+^GAFP^+^ astrocytes (Figure [4](#jah32429-fig-0004){ref-type="fig"}A through [4](#jah32429-fig-0004){ref-type="fig"}C). Consistent with our previous findings, we observed (1) an increase in oligodendrocyte lineage cells; (2) microglial expansion; and (3) astrogliosis early after severe CPB (Figure [4](#jah32429-fig-0004){ref-type="fig"}D through [4](#jah32429-fig-0004){ref-type="fig"}F, Table [9](#jah32429-tbl-0009){ref-type="table-wrap"}).[22](#jah32429-bib-0022){ref-type="ref"}, [23](#jah32429-bib-0023){ref-type="ref"}, [49](#jah32429-bib-0049){ref-type="ref"} At post‐CPB week 4 we also observed severe CPB‐induced oligodendrocyte dysmaturation (ie, reduction of CC1^+^ mature oligodendrocytes paired with an increase in Olig2^+^CC1^−^ immature oligodendrocytes) and prolonged microglial expansion following both mild and severe CPB (Figure [4](#jah32429-fig-0004){ref-type="fig"}G and [4](#jah32429-fig-0004){ref-type="fig"}H, Table [10](#jah32429-tbl-0010){ref-type="table-wrap"}).[22](#jah32429-bib-0022){ref-type="ref"}, [23](#jah32429-bib-0023){ref-type="ref"} On the other hand, astrocyte numbers were consistent in both groups on post‐CPB week 4 (Figure [4](#jah32429-fig-0004){ref-type="fig"}I). These cellular events caused by CPB significantly varied among the 7 WM regions analyzed (Figure [4](#jah32429-fig-0004){ref-type="fig"}D through [4](#jah32429-fig-0004){ref-type="fig"}I).

![CPB‐induced cellular events in the developing WM include an increase in oligodendrocyte lineage cells and their dysmaturation, acute astrogliosis, and prolonged microglial expansion. A, Olig2^+^ oligodendrocyte lineage cells and CC1^+^ mature oligodendrocytes. B, Iba1^+^ microglia. C, GS ^+^ GFAP ^+^ astrocytes. D, There is an increase in Olig2^+^ oligodendrocyte lineage cells early after severe CPB, but not at post‐CPB 4 weeks (n=3‐5 in each). More data are presented in Table [9](#jah32429-tbl-0009){ref-type="table-wrap"}. E, Iba1^+^ microglial expansion is observed both early and late following severe CPB (n=3‐5 in each). More data are presented in Table [9](#jah32429-tbl-0009){ref-type="table-wrap"}. F, Severe CPB results in acute astroligosis (n=3‐5 in each). More data are presented in Table [9](#jah32429-tbl-0009){ref-type="table-wrap"}. These cellular events following severe CPB vary among the 7 WM regions analyzed (D through F). G, There is a reduction of CC1^+^ mature oligodendrocytes after severe CPB, but not after mild CPB, 4 weeks postoperatively (n=3 in each). More data are presented in Table [10](#jah32429-tbl-0010){ref-type="table-wrap"}. H, Both mild and severe CPB insults cause prolonged microglial expansion (n=3 in each). More data are presented in Table [10](#jah32429-tbl-0010){ref-type="table-wrap"}. I, There are no differences in GS ^+^ GFAP ^+^ astrocyte numbers among the 3 CPB groups at postoperative week 4 (n=3 in each). More data are presented in Table [10](#jah32429-tbl-0010){ref-type="table-wrap"}. Early indicates postoperative days 3 and 10. Late indicates postoperative week 4. Data are shown as mean±SEM. ALIC indicates anterior limb of the internal capsule; BCC, body of the corpus callosum; CPB, cardiopulmonary bypass; IFWM, inferior frontal white matter; L‐PVWM, lateral periventricular white matter; MFWM, middle frontal white matter; M‐PVWM, medial periventricular white matter; SFWM, superior frontal white matter; w, weeks; WM, white matter.](JAH3-6-e005997-g004){#jah32429-fig-0004}

###### 

Comparison of Cell Numbers Between Time Period Groups After Severe CPB Stratified by WM Region

  Time Periods                               Control (n=5)   Early (n=3)   Late (n=3)   Control vs Acute   Control vs Long Term   Acute vs Long Term                     
  ------------------------------------------ --------------- ------------- ------------ ------------------ ---------------------- -------------------- --------- ------- ---------
  Olig2^+^ oligodendrocytes                                                                                                                                              
  BCC                                        180.0           3.4           210.5        15.8               184.7                  13.1                                   
  ALIC                                       102.4           15.2          142.8        40.4               130.3                  25.0                 0.081             
  M‐PVWM                                     144.6           27.9          173.1        23.9               166.3                  27.3                                   
  L‐PVWM                                     125.1           12.6          139.6        59.5               141.6                  12.9                                   
  SFWM                                       123.1           4.3           136.1        39.2               108.2                  13.8                                   
  MFWM                                       30.4            6.3           110.2        26.5               65.8                   41.0                 0.001             
  IFWM                                       17.8            6.3           63.2         28.9               55.3                   16.0                                   
  Olig2^+^CC1^−^ immature oligodendrocytes                                                                                                                               
  BCC                                        66.8            16.0          64.9         17.3               67.2                   15.4                                   
  ALIC                                       23.1            10.9          40.4         18.3               71.8                   42.6                           0.003   
  M‐PVWM                                     39.6            18.0          42.8         17.9               55.6                   17.4                                   
  L‐PVWM                                     28.0            23.4          36.4         34.2               68.1                   11.4                           0.015   
  SFWM                                       22.2            10.9          16.1         6.8                38.8                   7.4                                    
  MFWM                                       6.9             2.3           23.2         13.1               33.6                   31.5                                   
  IFWM                                       3.4             1.6           33.9         19.3               13.7                   5.3                                    
  Olig2^+^CC1^+^ mature oligodendrocytes                                                                                                                                 
  BCC                                        113.2           14.6          145.6        13.8               117.5                  4.3                  0.030             
  ALIC                                       79.2            5.1           102.3        26.5               58.5                   19.1                                   0.007
  M‐PVWM                                     105.0           26.8          130.4        15.7               110.6                  14.2                                   
  L‐PVWM                                     97.1            11.5          103.2        28.1               73.4                   7.3                                    
  SFWM                                       101.0           10.9          120.1        35.2               69.4                   20.4                           0.037   0.001
  MFWM                                       23.5            4.0           87.0         14.7               32.2                   9.7                  \<0.001           0.001
  IFWM                                       15.5            4.0           40.6         5.7                41.5                   13.4                                   
  Iba1^+^ microglia                                                                                                                                                      
  BCC                                        37.4            9.8           75.6         12.7               41.7                   21.0                                   
  ALIC                                       25.8            10.5          89.9         32.2               64.3                   6.9                                    
  M‐PVWM                                     30.5            10.1          116.3        49.2               61.7                   21.8                 0.013             
  L‐PVWM                                     36.5            11.7          172.9        103.8              70.3                   16.9                 \<0.001           0.007
  SFWM                                       32.9            10.1          217.3        123.8              107.4                  29.6                 \<0.001   0.037   0.004
  MFWM                                       30.5            10.5          160.7        71.6               65.6                   19.5                 \<0.001           0.014
  IFWM                                       25.5            11.9          137.5        66.2               102.3                  13.4                 0.001     0.030   
  GS^+^GFAP^+^ astrocytes                                                                                                                                                
  BCC                                        28.9            1.6           58.6         14.2               48.6                   12.7                 0.003             
  ALIC                                       32.4            1.9           71.0         12.9               39.5                   8.9                  \<0.001           0.002
  M‐PVWM                                     43.5            13.0          84.1         12.3               34.0                   6.9                  \<0.001           \<0.001
  L‐PVWM                                     33.2            2.7           36.1         8.3                24.2                   6.1                                    
  SFWM                                       26.6            3.9           49.0         9.7                55.1                   27.0                 0.034     0.005   
  MFWM                                       25.9            4.7           36.9         3.9                36.2                   3.7                                    
  IFWM                                       23.0            7.5           30.2         8.5                28.8                   11.4                                   

ALIC indicates anterior limb of the internal capsule; BCC, body of the corpus callosum; CPB, cardiopulmonary bypass; IFWM, inferior frontal white matter; L‐PVWM, lateral periventricular white matter; MFWM, middle frontal white matter; M‐PVWM, medial periventricular white matter; SFWM, superior frontal white matter; WM, white matter.

###### 

Comparison of Cell Numbers Between CPB Groups Stratified by WM Region

  CPB Group                                  Control (n=3)   Mild CPB (n=3)   Severe CPB (n=3)   Control vs Mild CPB   Control vs Severe CPB   Mild CPB vs Severe CPB                       
  ------------------------------------------ --------------- ---------------- ------------------ --------------------- ----------------------- ------------------------ --------- --------- ---------
  Olig2^+^ oligodendrocytes                                                                                                                                                                 
  BCC                                        181.0           7.9              190.2              4.7                   184.7                   13.1                                         
  ALIC                                       161.6           34.3             173.5              38.1                  166.3                   27.3                                         
  M‐PVWM                                     184.7           13.1             139.3              18.2                  100.1                   34.5                     0.044     \<0.001   
  L‐PVWM                                     139.3           18.2             137.3              4.3                   141.6                   12.9                                         
  SFWM                                       118.8           3.6              126.4              5.9                   108.2                   13.8                                         
  MFWM                                       100.3           14.7             100.1              34.5                  65.8                    41.0                                         
  IFWM                                       105.8           18.5             134.4              15.7                  55.3                    16.0                               0.021     \<0.001
  Olig2^+^CC1^−^ immature oligodendrocytes                                                                                                                                                  
  BCC                                        30.6            14.7             31.9               4.1                   67.2                    15.4                                         
  ALIC                                       13.4            10.7             16.1               1.5                   71.8                    42.6                               0.003     0.004
  M‐PVWM                                     32.3            27.7             37.5               23.8                  55.6                    17.4                                         
  L‐PVWM                                     27.9            17.3             19.4               2.5                   68.1                    11.4                               0.051     0.013
  SFWM                                       21.5            7.5              20.7               9.4                   38.8                    7.4                                          
  MFWM                                       29.2            19.7             36.2               14.4                  33.6                    31.5                                         
  IFWM                                       40.5            22.1             64.9               38.9                  13.7                    5.3                                          0.009
  Olig2^+^CC1^+^ mature oligodendrocytes                                                                                                                                                    
  BCC                                        153.3           4.1              155.4              6.9                   117.5                   4.3                                0.010     0.006
  ALIC                                       73.9            11.6             100.5              8.4                   58.5                    19.1                                         0.002
  M‐PVWM                                     129.4           17.5             136.0              27.7                  110.6                   14.2                                         
  L‐PVWM                                     111.4           6.9              117.9              5.4                   73.4                    7.3                                0.006     0.001
  SFWM                                       97.3            9.5              105.7              3.6                   69.4                    20.4                                         0.009
  MFWM                                       71.1            7.2              63.9               21.2                  32.3                    9.7                                0.005     0.027
  IFWM                                       65.2            17.3             69.5               23.1                  41.5                    13.4                                         
  Iba1^+^ microglia                                                                                                                                                                         
  BCC                                        19.0            7.8              15.1               2.5                   41.7                    21.0                                         
  ALIC                                       30.6            7.1              39.8               26.5                  64.3                    6.9                                0.039     
  M‐PVWM                                     27.8            10.1             41.4               20.2                  61.7                    21.9                               0.037     
  L‐PVWM                                     24.8            11.4             55.2               10.2                  70.3                    16.9                               0.003     
  SFWM                                       41.8            12.7             73.0               17.1                  107.4                   29.6                               \<0.001   0.034
  MFWM                                       33.2            11.3             91.6               11.3                  65.7                    19.5                     \<0.001   0.049     
  IFWM                                       29.9            18.7             84.0               3.6                   102.3                   13.4                     \<0.001   \<0.001   
  GS^+^GFAP^+^ astrocytes                                                                                                                                                                   
  BCC                                        48.5            20.3             43.6               8.4                   48.6                    12.7                                         
  ALIC                                       46.2            24.1             43.4               0.7                   39.5                    8.9                                          
  M‐PVWM                                     43.4            1.5              49.7               5.5                   34.0                    6.9                                          
  L‐PVWM                                     43.0            2.7              31.2               23.6                  24.2                    6.1                                          
  SFWM                                       27.6            10.4             24.9               4.7                   55.1                    27.0                               0.033     0.017
  MFWM                                       31.4            3.9              27.0               7.5                   36.3                    3.7                                          
  IFWM                                       32.4            16.9             26.0               4.9                   28.8                    11.4                                         

ALIC indicates anterior limb of the internal capsule; BCC, body of the corpus callosum; CPB, cardiopulmonary bypass; IFWM, inferior frontal white matter; L‐PVWM, lateral periventricular white matter; MFWM, middle frontal white matter; M‐PVWM, medial periventricular white matter; SFWM, superior frontal white matter; WM, white matter.

FA Increases Parallel Cellular Processes of WM Maturation During Normal Development {#jah32429-sec-0021}
-----------------------------------------------------------------------------------

In order to determine cellular events associated with changes in WM anisotropy, we first compared the change of cell numbers in 7 regions with FA of each corresponding region in control WM. There were no relationships between FA and cellular changes in a linear regression model (Table [11](#jah32429-tbl-0011){ref-type="table-wrap"}); on the other hand, we observed an inverted U‐shape pattern between FA and oligodendrocyte cell numbers (Figure [5](#jah32429-fig-0005){ref-type="fig"}A). When WM subdivisions---(1) CC; (2) IC; (3) DP; (4) SFWM (Table [2](#jah32429-tbl-0002){ref-type="table-wrap"})---were categorized and ranked based on mean FA value, numbers of oligodendrocyte and mature oligodendrocyte cells at CC (FA=0.41) and DP (FA=0.45) significantly increased compared with SFWM where lower FA (0.37) was measured (Figure [4](#jah32429-fig-0004){ref-type="fig"}B and [4](#jah32429-fig-0004){ref-type="fig"}C). Conversely, the numbers in IC (FA=0.51) significantly decreased compared with CC and DP (Figure [5](#jah32429-fig-0005){ref-type="fig"}B and [5](#jah32429-fig-0005){ref-type="fig"}C). Cellular processes underlying WM maturation involve expansion of oligodendrocyte lineages and axonal myelination through mature oligodendrocytes, followed by a decline of mature oligodendrocytes with maintaining myelination.[37](#jah32429-bib-0037){ref-type="ref"}, [40](#jah32429-bib-0040){ref-type="ref"}, [41](#jah32429-bib-0041){ref-type="ref"} Therefore, our results confirm FA as a useful image biomarker for WM maturation under normal physiological conditions in this model. Linear and nonlinear relations of FA with microglia and astrocyte cell numbers were not observed in control animals (Table [11](#jah32429-tbl-0011){ref-type="table-wrap"}).

###### 

Fractional Anisotropy and Cellular Changes

  Variable                                   *r* ~s~   *P* Value   Equation
  ------------------------------------------ --------- ----------- -----------------
  Control                                                          
  Olig2^+^ oligodendrocytes                  0.079     0.735       
  Olig2^+^CC1^−^ immature oligodendrocytes   −0.261    0.254       
  Olig2^+^CC1^+^ mature oligodendrocytes     0.183     0.428       
  Iba1^+^ microglia cells                    −0.414    0.062       
  GS^+^GFAP^+^ astrocytes                    0.369     0.099       
  Post‐CPB acute                                                   
  Olig2^+^ oligodendrocytes                  0.389     0.041       Y=292.0X+19.01
  Olig2^+^CC1^−^ immature oligodendrocytes   0.345     0.084       
  Olig2^+^CC1^+^ mature oligodendrocytes     0.356     0.066       
  Iba1^+^ microglia cells                    0.001     0.998       
  GS^+^GFAP^+^ astrocytes                    0.389     0.045       Y=103.1X+9.695
  Post‐CPB week 4                                                  
  Olig2^+^ oligodendrocytes                  0.364     0.018       Y=199.0X+52.12
  Olig2^+^CC1^−^ immature oligodendrocytes   0.047     0.767       
  Olig2^+^CC1^+^ mature oligodendrocytes     0.401     0.009       Y=182.0X+17.52
  Iba1^+^ microglia cells                    −0.506    0.001       Y=−161.8X+129.2
  GS^+^GFAP^+^ astrocytes                    0.047     0.767       

CPB indicates cardiopulmonary bypass.

In equations Y is cells per microm \^3 and X is FA.

![FA increases parallel cellular processes of WM maturation during normal development. A, Plot of FA and Olig2^+^ oligodendrocyte cell number in 7 WM regions shows an inverted U‐shape pattern among controls at 7 weeks of age (n=3 animals). B and C, When 4 WM subregions are ranked based on mean FA from left to right on X‐axis, changes of Olig2^+^ oligodendrocyte (B) and CC1^+^ mature oligodendrocyte cell (C) numbers display cellular processes underlying WM maturation that involve expansion of oligodendrocyte lineages and myelination through mature oligodendrocytes, followed by a decline of mature oligodendrocytes while maintaining myelination (n=3 animals). \**P*=0.05 vs SFWM, \*\**P*\<0.05 vs IC, \*\*\**P*\<0.05 vs SFWM and IC by the Kruskal‐Wallis followed by Mann‐Whitney U‐tests. ALIC indicates anterior limb of the internal capsule; BCC, body of the corpus callosum; CPB, cardiopulmonary bypass; FA, fractional anisotropy; IC, internal capsule; IFWM, inferior frontal white matter; L‐PVWM, lateral periventricular white matter; MFWM, middle frontal white matter; M‐PVWM, medial periventricular white matter; SFWM, superior frontal white matter; WM, white matter.](JAH3-6-e005997-g005){#jah32429-fig-0005}

Normal Correlation of FA With Oligodendrocyte Lineages Are Altered After Cardiac Surgery and CPB‐Induced Astrogliosis and Microglial Expansion {#jah32429-sec-0022}
----------------------------------------------------------------------------------------------------------------------------------------------

Next we analyzed the correlation between FA and cellular events in both mild and severe CPB groups. When cellular changes were divided between the acute period and week 4 following CPB, inverted U‐shaped distributions between FA and oligodendrocyte and mature oligodendrocyte numbers (Figure [5](#jah32429-fig-0005){ref-type="fig"}A through [5](#jah32429-fig-0005){ref-type="fig"}C), which we observed in control WM, were disrupted in both time periods following CPB, although linear relations of FA with oligodendrocytes and mature oligodendrocytes were seen (Figure [6](#jah32429-fig-0006){ref-type="fig"}A and [6](#jah32429-fig-0006){ref-type="fig"}C). The results demonstrate that CPB‐induced cellular events in oligodendrocyte lineages---acute expansion and dysmaturation---alter the sequence of FA with oligodendrocyte maturation in normal WM development.

![The association between FA and cellular processes of WM maturation is altered after cardiac surgery. CPB‐induced oligodendrocyte dysmaturation, astrogliosis, and microglial expansion affect FA changes, and FA on postoperative week 4 demonstrates CPB‐induced cellular alterations including reduction of mature oligodendrocytes and microglial expansion. A and B, FA changes are positively associated with Olig2^+^ oligodendrocyte numbers (A) and GS ^+^ GFAP ^+^ astrocyte numbers (B) in the acute period following CPB by Spearman rank‐order correlation coefficient (n=4 animals). C, Positive linear relations of FA with CC1^+^ mature oligodendrocytes are seen at week 4 after CPB by the Spearman rank‐order correlation coefficient rather than inverted U‐shape distributions (n=6 animals). D, There is a moderate negative association between FA and microglia number 4 weeks postoperatively by the Spearman rank‐order correlation coefficient (n=6 animals). More data are presented in Table [11](#jah32429-tbl-0011){ref-type="table-wrap"}. ALIC indicates anterior limb of the internal capsule; BCC, body of the corpus callosum; CPB, cardiopulmonary bypass; FA, fractional anisotropy; IFWM, inferior frontal white matter; L‐PVWM, lateral periventricular white matter; MFWM, middle frontal white matter; M‐PVWM, medial periventricular white matter; SFWM, superior frontal white matter; WM, white matter.](JAH3-6-e005997-g006){#jah32429-fig-0006}

In control animals, FAs were not associated with astrocyte and microglia numbers (Table [11](#jah32429-tbl-0011){ref-type="table-wrap"}). However, following CPB, FA changes were positively associated with GS^+^GFAP^+^ astrocyte numbers in the acute postoperative period (Figure [6](#jah32429-fig-0006){ref-type="fig"}B). Interestingly, a negative correlation between FA and microglia number was displayed at week 4 after CPB (Figure [6](#jah32429-fig-0006){ref-type="fig"}D). Together our results demonstrate that both CPB‐induced astrogliosis and microglial expansion affect FA changes after cardiac surgery.

FA at 4 Weeks After Cardiac Surgery Enables Identification of CPB‐Induced Cellular Events in Developing WM {#jah32429-sec-0023}
----------------------------------------------------------------------------------------------------------

The aforementioned results suggest complex correlations between FA and cellular changes after cardiac surgery. In other animal models the relationship between DTI indices and neuropathology also became less straightforward in complex pathological conditions.[15](#jah32429-bib-0015){ref-type="ref"} For instance in a mouse model of myelination injury, histology showed severe demyelination and inflammation, whereas diffusivity measured by in vivo DTI showed no significant difference from control animals.[50](#jah32429-bib-0050){ref-type="ref"}, [51](#jah32429-bib-0051){ref-type="ref"} In order to test such a scenario, we categorized 7 WMs into regions with FA change (BCC, SFWM, MFWM) and without FA change (anterior limb of the internal capsule, M‐PVWM, L‐PVWM, IFWM, Table [6](#jah32429-tbl-0006){ref-type="table-wrap"}) and compared the correlation of FA with the histological data. We found a positive relation of FA with oligodendrocyte and mature oligodendrocyte numbers on post‐CPB week 4: conversely, FA was negatively correlated with microglia number (Figure [6](#jah32429-fig-0006){ref-type="fig"}C and [6](#jah32429-fig-0006){ref-type="fig"}D, Table [11](#jah32429-tbl-0011){ref-type="table-wrap"}). When the correlation was compared between WMs with and without FA changes, slopes significantly differed between 2 categorized regions (Figure [7](#jah32429-fig-0007){ref-type="fig"}A and [7](#jah32429-fig-0007){ref-type="fig"}B). In each correlation, we found better fitness in the area with FA change compared with the WM without the change (Figure [7](#jah32429-fig-0007){ref-type="fig"}A and [7](#jah32429-fig-0007){ref-type="fig"}B), demonstrating that FA changes after CPB correspond with pathological events such as the reduction of mature oligodendrocytes and increase in microglia. Indeed, in BCC, SFWM, and MFWM, where significant FA reductions were seen after severe CPB (Figure [3](#jah32429-fig-0003){ref-type="fig"}B and [3](#jah32429-fig-0003){ref-type="fig"}C, Table [5](#jah32429-tbl-0005){ref-type="table-wrap"}), a lower number of mature oligodendrocytes paired with a higher microglia number was displayed (Figure [4](#jah32429-fig-0004){ref-type="fig"}G and [4](#jah32429-fig-0004){ref-type="fig"}H, Table [10](#jah32429-tbl-0010){ref-type="table-wrap"}). There were significant increases in FA following mild CPB compared with severe CPB in BCC and SFWM (Figure [3](#jah32429-fig-0003){ref-type="fig"}B and [3](#jah32429-fig-0003){ref-type="fig"}C). In these regions oligodendrocyte numbers in mild CPB were higher than those with severe CPB, although microglia numbers were lower (Table [10](#jah32429-tbl-0010){ref-type="table-wrap"}). Together our results suggest that FA changes on postoperative week 4 enable identification of CPB‐induced cellular alterations including reduction of mature oligodendrocytes and microglial expansion.

![FA is a powerful biomarker to define WM cellular alterations after cardiac surgery. A and B, When the correlation is compared in WM areas between with and without FA changes (BCC,SFWM,MFWM vs ALIC, M‐PVWM, L‐PVWM,IFWM), better fits in positive FA relation with mature oligodendrocytes (A) and negative association with microglia (B) are observed in the area with FA change (black line) compared with the WM without change (dotted line), suggesting that FA changes on postoperative week 4 enable identification of CPB‐induced cellular alterations (n=6 animals). C and D, There is an unchanged relation between FA and the number of mature oligodendrocyte cells (C) and microglia (D) between mild and severe CPB groups (n=6 animals). ALIC indicates anterior limb of the internal capsule; BCC, body of the corpus callosum; CPB, cardiopulmonary bypass; FA, fractional anisotropy; IFWM, inferior frontal white matter; L‐PVWM, lateral periventricular white matter; MFWM, middle frontal white matter; M‐PVWM, medial periventricular white matter; SFWM, superior frontal white matter; WM, white matter.](JAH3-6-e005997-g007){#jah32429-fig-0007}

On the other hand, we did not observe such differences between mild and severe CPB insults in corrections of FA with oligodendrocytes, mature oligodendrocytes, and microglia (Figure [7](#jah32429-fig-0007){ref-type="fig"}C and [7](#jah32429-fig-0007){ref-type="fig"}D). Although both FA and cellular alterations significantly vary according CPB‐induced insults (Table [10](#jah32429-tbl-0010){ref-type="table-wrap"}, Figure [4](#jah32429-fig-0004){ref-type="fig"}), our analyses indicate that the relations between FA changes and cellular events are not affected by distinct pathological conditions due to CPB. Altogether our results demonstrate that FA is a powerful biomarker to define WM cellular alterations after cardiac surgery.

Effects of Mature Oligodendrocyte and Microglia Numbers on FA Reduction Following CPB {#jah32429-sec-0024}
-------------------------------------------------------------------------------------

Neurocognitive deficits in adolescents with D‐transposition of the great arteries repaired in infancy are associated with WM FA reduction.[17](#jah32429-bib-0017){ref-type="ref"} Changes in FA during the early postnatal period persist into adolescence and young adulthood in subjects born prematurely.[8](#jah32429-bib-0008){ref-type="ref"} Thus, preventing or recovering WM FA reduction after neonatal cardiac surgery could be a promising avenue to improve neurological impairment in CHD patients. In order to develop a cellular‐based treatment strategy, we investigated the effects of mature oligodendrocyte and microglia cell numbers on FA reduction after CPB.

For the analyses we first examined 2 cutoff values, (1) 1 SD below the mean FA and (2) 2 SDs below the mean FA, in order to compare the definition with better fit for the estimation of cellular events associated with CPB‐induced FA reduction. Our analyses identified that the stronger relationship was between FA reduction \>1 SD and change in mature oligodendrocytes relative to control. The area under the ROC curve was 0.800, which represents excellent predictive accuracy (95% confidence interval 0.652‐0.951, *P*\<0.001) between CPB‐induced FA reduction and the change in number of mature oligodendrocytes relative to control (Table [12](#jah32429-tbl-0012){ref-type="table-wrap"}). The box‐and‐whisker plot shows that the change in number was considerably larger when FA reduction was \>1 SD. The change was in the negative direction when FA decreased after CPB (Figure [8](#jah32429-fig-0008){ref-type="fig"}A). The Youden J‐index revealed that the optimal cutoff value for predicting FA reduction \>1 SD was a decrease of 8 or more in the density of WM mature oligodendrocytes, which translated into a sensitivity of 91% and a specificity of 76%. From logistic regression, a change in number of at least −8 compared to control was associated with an odds of FA reduction \>1 SD of over 30 (odds ratio=30.4, 95% confidence interval 5.2‐178.4, *P*\<0.001). The probability curve illustrates negative effects of mature oligodendrocyte numbers on FA reduction (Figure [8](#jah32429-fig-0008){ref-type="fig"}B). For example, decreases of 20 and 40 mature oligodendrocytes (per 100 μm^3^) are associated with a probability of FA reduction of 60% and 80%, respectively (Figure [8](#jah32429-fig-0008){ref-type="fig"}B, Table [13](#jah32429-tbl-0013){ref-type="table-wrap"}).

###### 

Likelihood Ratio Test as Fractional Anisotropy Reduction Relates to Changes in Mature Oligodendrocyte and Microglia Cells

                                      LRT     *P* Value   AUC     95%CI
  ----------------------------------- ------- ----------- ------- ----------------
  All 7 WM regions (n=42)                                         
  Change in mature oligodendrocytes   10.03   0.002       0.800   0.652 to 0.951
  Change in microglia cells           4.43    0.035       0.720   0.558 to 0.884
  BCC, SFWM, MFWM (n=18)                                          
  Change in mature oligodendrocytes   24.73   \<0.0001    1.000   0.998 to 1.000
  Change in microglia cells           0.71    0.405       0.650   0.374 to 0.926

AUC indicates area under a quantity‐time curve; BCC, body of the corpus callosum; CI, confidence interval; FA, fractional anisotropy; LRT, likelihood ratio test from logistic regression; MFWM, middle frontal white matter; SFWM, superior frontal white matter; WM, white matter.

![Regions most resilient to CPB‐induced FA reduction maintain mature oligodendrocytes and inhibit microglial expansion. A, The box‐and‐whisker plot for mature oligodendrocyte number relative to control on post‐CPB week 4. There are significant reductions in the change of number in FA reduction‐positive WM (−21.7±21.5) compared with FA reduction‐negative WM (+0.1±20.8) by Mann‐Whitney U‐test. Median values are presented in the box‐and‐whisker plot. B, Probability curves of FA reduction as a function of mature oligodendrocyte number relative to control on post‐CPB week 4 indicate negative effects of mature oligodendrocyte numbers on FA reduction. C, The box‐and‐whisker plot for microglia number relative to control. Significant increase in the change of number is observed in FA reduction‐positive WM (+42.4±21.4) compared with FA reduction‐negative WM (+28.9±28.4) by Mann‐Whitney U‐test. Median values are presented in the box‐and‐whisker plot. D, Probability curves of FA reduction as a function of the microglia number relative to control on post‐CPB week 4 illustrate positive effects of microglia numbers on FA reduction. CPB indicates cardiopulmonary bypass; FA, fractional anisotropy; OL, oligodendrocyte. More data are presented in Tables [13](#jah32429-tbl-0013){ref-type="table-wrap"} and [14](#jah32429-tbl-0014){ref-type="table-wrap"}.](JAH3-6-e005997-g008){#jah32429-fig-0008}

###### 

Change in Mature Oligodendrocytes and Probability of Fractional Anisotropy Reduction \>1 SD

  Change in Number of Mature Oligodendrocytes (per 100 μm^3^)   Probability (%)   95% Confidence Interval
  ------------------------------------------------------------- ----------------- -------------------------
  −50                                                           86                60% to 97%
  −45                                                           83                58% to 95%
  −40                                                           80                55% to 93%
  −35                                                           76                52% to 90%
  −30                                                           71                49% to 86%
  −25                                                           66                46% to 81%
  −20                                                           60                42% to 76%
  −15                                                           55                37% to 71%
  −10                                                           49                32% to 65%
  −5                                                            43                26% to 60%
  0                                                             37                21% to 56%
  5                                                             31                16% to 53%
  10                                                            27                12% to 50%
  15                                                            22                8% to 47%
  20                                                            18                6% to 44%
  25                                                            15                4% to 42%
  30                                                            12                3% to 40%
  35                                                            10                2% to 38%
  40                                                            8                 1% to 35%

Although the relation was less strong compared with the mature oligodendrocyte number, FA reductions were also associated with an increase in microglia cells relative to control (Figure [8](#jah32429-fig-0008){ref-type="fig"}C). The area under the receiver operating characteristic curve in the number of microglia demonstrated predictive accuracy of a significant FA reduction (Table [12](#jah32429-tbl-0012){ref-type="table-wrap"}), such that the increase in 80 WM microglia cells (per 100 μm^3^) was associated with a nearly 80% probability in FA reduction following CPB (Figure [8](#jah32429-fig-0008){ref-type="fig"}D, Table [14](#jah32429-tbl-0014){ref-type="table-wrap"}). Interestingly, our theoretical curves showed that no changes of mature oligodendrocyte and microglia numbers relative to control are still associated with 37% and 25% chances in FA reduction in each WM region (Figure [8](#jah32429-fig-0008){ref-type="fig"}B and [8](#jah32429-fig-0008){ref-type="fig"}D). The results suggest the notion that other cellular events secondary to CPB also contributed to FA reduction after cardiac surgery.

###### 

Change in Microglia and Probability of Fractional Anisotropy Reduction \>1 SD

  Change in Number of Microglia (per 100 μm^3^)   Probability (%)   95% Confidence Interval
  ----------------------------------------------- ----------------- -------------------------
  −10                                             20                5% to 52%
  −5                                              22                7% to 53%
  0                                               25                9% to 54%
  5                                               28                11% to 54%
  10                                              31                14% to 55%
  15                                              34                17% to 56%
  20                                              37                21% to 57%
  25                                              40                25% to 59%
  30                                              44                28% to 61%
  35                                              47                32% to 63%
  40                                              51                35% to 67%
  45                                              55                38% to 70%
  50                                              58                40% to 75%
  55                                              62                41% to 79%
  60                                              65                42% to 82%
  65                                              68                43% to 86%
  70                                              71                44% to 89%
  75                                              74                44% to 91%
  80                                              77                45% to 93%
  85                                              79                45% to 95%
  90                                              81                45% to 96%
  95                                              83                46% to 97%
  100                                             85                46% to 98%

Discussion {#jah32429-sec-0025}
==========

This study is the first to reveal region‐specific FA changes in the porcine WM similar to those that occur in humans and to define corresponding time periods in human WM development. In addition, we identify developmental stage‐dependent WM vulnerability against insults associated with cardiac surgery and reveal that WM regions in the frontal cortex are particularly susceptible. Moreover, our data demonstrate region‐specific and insult‐dependent FA alterations using an animal model anatomically and physiologically similar to humans. In conjunction with detailed cellular assays, the present study also determines that alterations of WM microstructure are affected by CPB‐induced oligodendrocyte dysmaturation, astrogliosis, and microglial expansion. Furthermore, FA enables capturing such cellular events postoperatively. Finally, our study also defines a targeted cellular window for reducing the risk of FA reduction, thus contributing to developing a cellular‐based treatment strategy for the improvement of neurodevelopmental impairment in the CHD population.

The tremendous power of transgenic/gene‐knockout technologies in rodent animal models has led to great success in developing our understanding of cellular/molecular processes underlying brain development and its pathology. However, there is a growing need for a large‐animal model for better transition of discoveries derived from rodent studies to clinically relevant questions. Our previous attempt to define the epochs in human WM development that correspond to this porcine model was prevented by a lack of cellular investigations in the postnatal human brain.[22](#jah32429-bib-0022){ref-type="ref"} However, the clinically relevant DTI approach in this study has been able to identify corresponding time windows of porcine WM relative to human WM development. Our results demonstrate that FA at postnatal 3 and 7 weeks in our model is equivalent to those of the early infant stage in the human (postconception 41‐53 and 53‐60 weeks), contributing to a better understanding of CPB‐induced WM alteration in human infants. A wide variety of brain regions possess distinguished developmental time courses, and the diversity differs among various species. Research through innovative imaging technologies is now producing a revolutionary new dynamic picture of the development and pathology in the human brain.[52](#jah32429-bib-0052){ref-type="ref"} Introducing advanced neurotechnologies into gyrencephalic animals including swine and lambs, as we performed in this study, will provide a wealth of bidirectional information in the research directed toward complex human brain development and a wide range of neurodevelopmental disorders.

Postimage processing of MRI data is advancing rapidly. Nevertheless, defining/comparing DTI indices in all regions of the complex human WM are labor‐intensive and time‐consuming procedures that prevent rapid feedback as valid biomarkers for clinical brain injury. Within various WM areas the present study found significant FA alterations in the corpus callosum (GCC, BCC) and subcortical WM (SFWM, MFWM) in the frontal cortical lobe after CPB, suggesting that FA in the frontal cortex should be a clinically relevant biomarker in WM injury after cardiac surgery. The frontal cortex plays an essential role in executive function, social cognition, and attention,[53](#jah32429-bib-0053){ref-type="ref"}, [54](#jah32429-bib-0054){ref-type="ref"}, [55](#jah32429-bib-0055){ref-type="ref"} and the connectivity through WM in those regions is crucial for proper development of such neurological functions.[9](#jah32429-bib-0009){ref-type="ref"}, [56](#jah32429-bib-0056){ref-type="ref"} Because impairments in executive function, social cognition, and/or attention are well documented in patients with CHD,[1](#jah32429-bib-0001){ref-type="ref"}, [3](#jah32429-bib-0003){ref-type="ref"}, [57](#jah32429-bib-0057){ref-type="ref"} our data also indicate that reducing and recovering WM alterations of the frontal cortex will likely improve lifelong neurodevelopmental consequences in the CHD population.

Our findings suggest that the regions most resistant to FA reduction maintained their mature oligodendrocyte population and inhibited microglial expansion after CBP. Because of our study design, we were unable to determine primary cellular events underlying CPB‐induced FA alteration or to verify relationships between cellular events and FA changes observed in the present study. On the other hand, our assay regarding risk analysis in FA reduction on mature oligodendrocytes shows more statistical power compared with microglia number. When the analyses were restricted to BCC, SFWM, and MFWM, where significant FA reductions were observed at post‐CPB week 4, the relationship in FA reduction was highly significant for decreased mature oligodendrocytes (area under the curve 1.000); however, the change in microglia number was not correlated with FA reduction (Table [12](#jah32429-tbl-0012){ref-type="table-wrap"}). The results may indicate that restoring mature oligodendrocytes can be primarily targeted to improve microstructural alterations of developing WM. A recent study using a rodent model of developmental WM injury has demonstrated that heparin‐binding epidermal growth factor after hypoxic exposure reduced oligodendrocyte death, promoted oligodendrocyte generation, and improved functional/behavioral recovery through endogenous repair mechanisms.[58](#jah32429-bib-0058){ref-type="ref"} Several failures of clinical trials investigating treatment of ischemic brain injury have spurred a consensus that supports the need to determine cross‐species efficacy of new therapies. The effects of drugs in pigs resemble the effects in humans more closely than other laboratory animals.[59](#jah32429-bib-0059){ref-type="ref"} Therefore, our unique animal model may lead to a highly translational study to develop new pharmacological treatments for WM injury in children with CHD as well as other neurodevelopmental disorders such as preterm infants.

Our statistical model suggests that other cellular events also contributed to CPB‐induced FA changes. Certainly, myelination and/or axonal swelling would play an important role in alterations of FA after cardiac surgery.[15](#jah32429-bib-0015){ref-type="ref"}, [60](#jah32429-bib-0060){ref-type="ref"} Electron microscopy is required to analyze/define such structural changes.[58](#jah32429-bib-0058){ref-type="ref"}, [60](#jah32429-bib-0060){ref-type="ref"} However, in the present study the investigation using electron imaging paired with immunohistochemistry was limited by different fixation methodologies. Recent advances in the optical clearing method have provided the visualization of molecularly and immunologically labeled structures within large intact tissues in 3 dimensions and allow analysis of complex structures that are not contained within 2‐dimensional planes.[61](#jah32429-bib-0061){ref-type="ref"} Future studies using electron microscopy or optical clearing protocols in this animal model will provide novel structural insights into WM dysmaturaion and injury in patients with CHD.

Our study demonstrates that the piglet brain is a powerful model to study human WM development. The piglet also allows us to perform CPB during the neonatal period,[22](#jah32429-bib-0022){ref-type="ref"}, [23](#jah32429-bib-0023){ref-type="ref"} which causes specific pathological conditions in the developing brain with CHD.[13](#jah32429-bib-0013){ref-type="ref"} However, because of the high costs involved, the present study using the piglet survival model with CPB had limitations regarding the number of animals used and the number of in vivo imaging experiments performed, as compared with rodent studies. The small sample size may affect statistical analyses such as the cutoff value or threshold in logistic regression modeling and cause‐and‐effect relationships between cellular events and FA changes. Our future studies using the model should provide more statistical power and improve our knowledge about the complex factors analyzed in this study such as different developmental time windows, various WM areas, and various brain insults associated with cardiac surgery. We used manual ROI measurements to determine DTI indices in the porcine WM. For further improvement of quantitative characterization in the model, development of a detailed WM atlas as established for the rodent brain[62](#jah32429-bib-0062){ref-type="ref"} is also needed for the porcine brain. Although we accounted for multiple testing in the 31 WM regions imaged, cellular analyses in the present study was limited to 7 WM regions because of the labor‐intensive and time‐consuming nature of quantification of immunohistochemical assays using the piglet brain. Extending our cellular assay in our future studies and defining the relationship between image biomarkers and cellular events to all WM regions of the piglet brain will undoubtedly enhance our understanding of complex WM development and injury after pediatric cardiac surgery.

It has been well documented that the presence of CHD in utero can induce WM dysmaturation resulting in immaturity at birth, which impacts the risk of subsequent injury.[7](#jah32429-bib-0007){ref-type="ref"}, [63](#jah32429-bib-0063){ref-type="ref"} Our piglet CPB model enabled us to reproduce unique surgery‐related stresses to the neonatal human brain with CHD. However, the model does not take into account the potential impact of in utero development and pre‐CPB injury to the WM, which likely alters the susceptibility to subsequent injury. Our recent study has identified several pathological signatures of the fetal human brain with CHD that can be reproduced and modeled with the developing piglet brain under chronic hypoxia.[20](#jah32429-bib-0020){ref-type="ref"} A combined experimental paradigm using piglets exposed to both hypoxia and CPB will allow us to investigate the overall impact of CHD and subsequent cardiac surgery and will help further understanding of multietiological complex WM dysmaturation in the CHD population.

The present study showed that decreases of 20 and 40 mature oligodendrocytes (per 100 μm^3^) are associated with a probability of FA reduction of 60% and 80%, respectively. Conversely an increase of 40 mature oligodendrocytes involves only 8% probability of CPB‐induced FA reduction, suggesting that increasing mature oligodendrocyte number (eg, 40 mature oligodendrocytes per 100 μm^3^) can be targeted to recover WM microstructural alterations after CPB. It has been well documented that the immature population in the oligodendrocyte lineage such as oligodendrocyte progenitors retains their mitotic and differentiation potential, as the brain is able to endogenously replenish damaged WM.[37](#jah32429-bib-0037){ref-type="ref"}, [58](#jah32429-bib-0058){ref-type="ref"}, [64](#jah32429-bib-0064){ref-type="ref"}, [65](#jah32429-bib-0065){ref-type="ref"}, [66](#jah32429-bib-0066){ref-type="ref"} WM regions in the frontal cortex regions affected by severe CPB insults such as BCC, SFWM, or MFWM still contain significant numbers of immature oligodendrocytes at postoperative week 4. Our previous studies in both mouse and piglet models demonstrated that oligodendrocyte progenitor cells were resistant to CPB‐induced insults.[22](#jah32429-bib-0022){ref-type="ref"}, [67](#jah32429-bib-0067){ref-type="ref"} Taken in conjunction, our study supports the concept that optimal treatment for successful WM development in CHD requires therapy aimed at promoting endogenous recovery through the action of oligodendrocyte progenitors including proliferation, differentiation, and myelination.

In summary, our study demonstrated that the piglet brain is a powerful model to study human WM development. FA changes after surgery are region specific and insult dependent and are associated with oligodendrocyte dysmaturation, astrogliosis, and microglial expansion. Reducing and recovering alterations of oligodendrocyte development in the frontal cortex can be targeted to improve lifelong neurodevelopmental consequences in the CHD population. Further studies in this model will provide exceptional data needed to interpret human imaging studies.
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